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Recent progress in extrusion 3D bioprinting of hydrogel biomaterials 
for tissue regeneration: a comprehensive review with a focus on 
advanced fabrication techniques
Mohsen Askaria,b, Moqaddaseh Afzali Naniza,b, Monireh Kouhic, Azadeh Saberid, Ali Zolfaghariane, 
Mahdi Bodaghia,*
Over the last decade, 3D bioprinting has received immense attention from research communities for developing functional 
tissues. Thanks to the complexity of tissues, various bioprinting methods are exploited to figure out the challenges of tissue 
fabrication, in which hydrogels are widely adopted as a bioink in cell printing technologies based on the extrusion principle. 
Thus far, there is a wealth of the literature proposing the crucial parameters of extrusion-based bioprinting of hydrogel 
biomaterials (e.g., hydrogel properties, printing conditions, and tissue scaffold design) toward enhancing performance. 
Despite the growing research in this field, numerous challenges that hinder advanced applications still exist. Herein, the 
most recently reported hydrogel-based bioprinted scaffolds, i.e., skin, bone, cartilage, vascular, neural, and muscular 
(including skeletal, cardiac, and smooth), are systematically discussed with an emphasis on the advanced fabrication 
techniques from tissue engineering perspective. Methods covered include the multiple-dispenser, coaxial, and hybrid 3D 
bioprinting. The present work is a unique study to figure out the opportunities of the novel techniques to fabricate 
complicated constructs with structural and functional heterogeneity. Finally, the principal challenges of current studies and 
a vision of future research are presented.
Introduction
Tissue engineering (TE) is an interdisciplinary field that comprises 
applying principles of life sciences and materials engineering to 
restore, maintain, and enhance tissue function [1,2]. By harvesting 
cells from a patient (or other resources) and seeding onto or 
incorporating into a tissue scaffold, the cell-scaffold construct tends 
to maturation to being a functional construction. It could be 
implanted into the patient to help repair or heal the damaged tissues 
[3]. The typical design of tissue scaffolds as functional constructs 
depends on the understanding of its composition and organization. 
Accordingly, appropriate architectures and biomaterials/cells to 
mimic the key properties of tissue should be carefully selected [4]. In 
this regard, a wide variety of cells, biomaterials, growth factors, and 
other supporting components have been investigated to create 
functional constructs [5–8]. However, scaffold-based strategies not 
only have often failed to imitate complex structures of native tissues 
but also remained ineffective for placing multiple types of cells in 
desired positions [9].
In recent years, three-dimensional (3D) bioprinting has occupied a 
prominent place among all other methods for producing tissue 
scaffolds to bridge the divergence between artificially engineered 
tissue constructs and native tissues [10–12]. Due to increasingly 
emerging interests, its global market, which was estimated at nearly 
$ 487 million in 2014, is foreseen to reach $ 1.82 billion in 2022 [13]. 
Using 3D bioprinting techniques, bioink (mainly comprised of 
biomaterials, living cells, and/or bioactive molecules) is printed in a 
predesigned manner and incorporated with living cells as dynamic 
structures with functions (e.g., growth and proliferation) within 
scaffolds to regenerate target tissues [14–16]. Besides, it is a rapid 
and inexpensive method to generate geometrically well-defined 
scaffolds [17], and offers precise control over the composition of cells 
and biomaterials, associated with spatial distributions, and 
architectural accuracy [12,18]. Moreover, its ability for precise 
placement of high-density cells in the desired location and multiple 
types of cells in an orderly fashion mimics heterogeneous 
architectures of native tissues. It also allows forming vascular 
structures capable of recapitulating structural features of human 
tissues [9]. 
Current 3D bioprinting technologies for engineering functional 
human tissues and organs that recapitulate their native prototypes 
can be categorized based on four major governing approaches:  1) 
droplet-based, 2) extrusion-based, 3) laser-induced forward transfer, 
and 4) stereolithography bioprinting, and each of them can be more 
sub-categorized based on the specific mechanisms with which 
materials and cells are positioned [19–21]. Among these, one of the 
most interesting explored technique  is extrusion-based bioprinting 
(EBB), which extrudes or dispenses continuous strands or fibers of 
biomaterials to form 3D scaffold structures [17,22] in a layer-by-layer 
manner [23]. It should be mentioned that although novel bioprinting 
techniques are developing (e.g., contactless [24] and volumetric 
bioprinting [25]), EBB remains the most prevalent employed 
approach research and commercial areas to fabricate 3D cell-laden 
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scaffolds due to its cost-effectiveness, accessibility and capacity to 
replicate tissue complexity [20,21,26].
The main advantages of EBB compared to other 3D printing methods 
have been concluded as follows: 1) producing tissue scaffolds using 
a wide variety of biomaterials and cell types, even hydrogel polymers 
with suspended cells [27]; 2) successfully layer-by-layer depositing of 
biomaterials with physiological cell density in a designed way [28]; 3) 
relatively less process-induced cell damage compared to other 
techniques [22,29]; and 4) great potential for regulating and 
conducting stem cell growth and differentiation for many 
applications [15]. Despite some challenges such as limited strand 
resolution (typically greater than 100 µm) [15], and restricted 
biomaterials choice [17], the stated advantages associated with 
economical aspects and commercially availability have made EBB the 
most popular technique amongst tissue engineers and researchers 
[30].
Although various polymeric biomaterials have been employed as 
scaffold matrices, which had adequate qualities to provide necessary 
support and properties required for tissue growth, they had 
insufficient cell mimicking quality and inadequate interaction with 
stromal cells, which are essential in promoting tissue regeneration 
[31,32]. An alternative approach to overcome the restrictions of 
these polymeric scaffolds was designing hydrogel-based bioprinted 
constructs [33]. Hydrogels are well-known as an appropriate 
environment for scaffold development because of their composition, 
and structure is somewhat similar to the extracellular matrix (ECM) 
of much human tissue and ease of preparation using relatively mild 
conditions and aqueous chemistries. They have gained widespread 
popularity in the recent years based on their ability to maintain a 
distinct and porous 3D structure, to provide mechanical support for 
the cells in the engineered tissues, to adapt with interchangeable sol-
gel conditions, to simulate the native extracellular matrix, to retain 
high water content, to achieve high cell seeding density and 
homogenous cell distribution throughout the scaffold [34–36]. Their 
high water content provides a hydrated tissue-like environment 
which is appropriate for cell incorporation, and enhances the cell 
viability in bioprinting in a hydrated and mechanically stable 3D 
environment [37]. These structural properties provide hydrogels to 
be utilized as tissue scaffolds in the body by increasing the influx of 
cell metabolites and the disposal of cell wastes through their pores 
[38,39]. A large and growing body of the literature in recent years has 
investigated hydrogels concerning their origin, structural, chemical, 
and biological characteristics in nature [4,40–42]. There are also 
systemically discussions in terms of suitable hydrogel-forming 
polymers for tissue engineering according to origin and nature of the 
polymer, hydrogel-forming mechanisms, crosslinking mechanisms, 
modification approaches, physical, chemical or biological properties, 
their functionality and printability and its mostly affected printing 
parameters [31,43,44]. 
To answer the question that what ideal properties of an extrusion-
based hydrogel bioprinted scaffolds are, there is a wealth of the 
literature concentrating on the crucial parameters of EBB such as 
hydrogel parameters, printing conditions, and tissue scaffold design 
[9,10,19,36,45–48]. Also, some researchers have extended the 
discussion by investigating the optimized performance of bioprinting 
in native tissue development based on the simultaneous regulation 
of the main practical parameters of EBB [37]. However, reviewing 
limitations and potentials of tissues scaffolds in the EBB of polymeric 
hydrogels has not been well-documented. In this review, recently 
developed bioprinted scaffolds, i.e., skin, bone, cartilage, vascular, 
neural, and muscular (including skeletal, cardiac, and smooth), are 
discussed with a focus on novel approaches to building constructs 
(Figure 1). Moreover, this review will provide recommendations for 
future challenges in 3D bioprinting and perspectives for advanced 
researches in this framework. This review is not meant to be 
exhaustive but would offer the most prominent advances in their 
respective fields, and the most promise for prospective studies.
EBB strategies
In an EBB system, the positioning process allows the dispensing head 
to deposit the bioink onto the printing stage through three 
mechanisms: pneumatic-, piston-, or screw-based system [49]. Since 
the manufacturing process strongly affects the geometry of the 
scaffolds, there are numerous reports on the practical parameters in 
detail [9,10,19,42,46,50]. Here, it is focused on the outcomes of 
various techniques on the scaffold construction based on the TE 
perspective and fabrication methodology. From the TE perspective, 
direct and indirect, in situ and in vitro, and also scaffold-free versus 
scaffold-based bioprinting methods are considered for tissue 
fabrication. Besides, regarding the limitation of conventional 
bioprinting technology to fulfil all the conditions, advanced EBB 
fabrication methods have been developed, which could be generally 
classified into multiple-dispenser, coaxial, and hybrid bioprinting 
[17]. 
One of the most prevalent methods for micro-extrusion of multi-
materials is the application of multiple nozzles enabling 
simultaneous deposition of various bioinks with minimum cross-
contamination [21,51]. To be more specific, fabrication of practical 
constructs utilizing multi-dispenser system provides the capability of 
simultaneous deposition of multiple biomaterials and cells in a 
uniformly blended form with minimum cross-contamination, which 
is promising for fabricating hydrogel-based composite scaffolds (e.g., 
combination of hydrogels with synthetic polymers or sacrificial 
materials) [52]. 
However, the complexity and high cost of assembling the required 
robotic system hinder the broad application of this method. Thus, 
advanced fabrication techniques are necessary to generate complex 
constructs with controlled architectures and adequate mechanical 
properties [53]. Employing coaxial bioprinting (a configuration 
featuring two or more capillary nozzles connected in a coaxial 
fashion) would result in a more complex structure that would benefit 
TE applications such as vascularization [54]. Core/shell geometry 
seems promising in creating vascular networks due to its specific 
characteristics: (1) capacity of fabricating hierarchical, multi-layer 
tissue constructs with desirable biological and mechanical properties 
using multi-material and cellular constructs (2) increasing cell 
viability during cultivation, and (3) tuning the biophysical and 
biological properties of the vessel construct [55,56]. 
One of the freshest trends in regenerative medicine is the 
improvement of 3D-printing hydrogel scaffolds with biomimetic 
structures. However, it has been almost hard to achieve extremely 
biomimetic hydrogel constructs with proper mechanical properties 
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resembling the natural tissue [57,58]. Therefore, hybrid bioprinting 
techniques have been introduced to fabricate more complex 
constructs, e.g., a combination of a UV-light beam with EBB, 
integration of a multi-dispenser system with coaxial configurations 
or electrospinning technology.
Despite providing a controllable geometric configuration (macro-
architecture) and pore size, shape, interconnection, and spatial 
distribution (micro-architecture), 3D printing systems fail to create 
surface nano topographies, which are beneficial to enhance the 
performance of 3D printed constructs [59,60]. On the other hand, for 
the electrospun nanofiber scaffolds, although the porosity is high, 
even up to 90%, the pore size is too small for cells to migrate and 
infiltrate. Besides, electrospun fibers typically form 2D membranes 
with low thicknesses rather than bulk 3D scaffolds, and fibrous 
scaffolds usually have poor mechanical properties due to the high 
surface-area-to-volume ratios and porosity [61–63]. To overcome 
these issues, and also to mimic ECM matrix, EBB technique has been 
consolidated with electrospinning to develop scaffolds possessing 
advantages of different kinds of materials only in one construction 
[64–67]. In other words, joining 3D printing and electrospinning can 
make their particular advantages complementary and improve the 
capability of developing functional biomimetic scaffolds [68–70]. 
Furthermore, the emerging microfluidic organs-on-a-chip platform 
with widespread applications has opened up a new window to create 
more complex constructs [71]. The combination of bioprinting with 
organ-on-a-chip technology enables direct cell printing and/or 
patterning in microfluidic devices, production of the biomimetic 
heterogeneous microenvironment, and complex 3D microstructures 
[72,73]. It also provides the production of complex and biomimetic 
in vitro models for simulation, mechanistic biological studies and 
drug testing [74]. 
An overview concerning the application of advanced fabrication 
strategies of EEB for tissue engineering is presented in Table 1.
Tissue Bioprinting
Skin
As the largest and highly complex organ of the body, the skin serves 
as a protective shield against pathogens and irritants, antioxidants, 
physical and UV damage, and any external harmful agents [75,76]. 
Being in a direct contact with the external environment makes it 
highly susceptible to different varieties of injuries [77,78]. Regarding 
the wound size, extent, and depth, researchers have been 
developing numerous types of wound dressings or natural-based 
skin substitutes [79,80]. Despite all the advancements attained so 
far, several limitations with the use of autografts, allografts, and 
wound dressings [81] have led to the development of tissue-
engineered skin substitutes [82], so that, it holds great promises for 
improving the treatment of skin defects [83,84]. In response to the 
limitations of mentioned techniques, combined with a foreseen 
higher demand for artificial skin [85,86], 3D bioprinting was exploited 
to facilitate the simultaneous and highly specific deposition of 
multiple types of skin cells and biomaterials, i.e., a process that is 
lacking in conventional skin tissue-engineering approaches [87].
The skin that is almost thin, layered, and structured nature, along 
with easy access to cell sources, has promoted the immediate 
adoption of 3D bioprinting technology for the skin TE [88]. Further, 
3D bioprinting serves as an innovative strategy to overwhelm the 
current impasses in the manufacturing of skin tissue, such as poor 
vascularization, absence of hair follicles, and sweat glands in the 
construct [42,89]. Among various 3Dbioprinting techniques, to date, 
EBB has been accepted as the most promising approach for 
generating skin or soft tissues’ constructs [76,90].
An ideal bioprinted skin should have specific characteristics such as 
biocompatibility, desired mechanical properties, proper surface 
chemistry, and be high porosity with a network of interconnected 
pores that will allow cells to attach and capability of transferring 
nutrients and eliminating wound exudates [42]. Accessible literature 
review reveals that a variety of biomaterials have been widely 
studied for the generation of skin grafts [91–93], in which the most 
common materials are hydrogels [94–99]. However, the commonly 
available natural polymers besides synthetic polymers cannot 
provide the complex microenvironment analogous with the natural 
ECM [27]. This complexity can be ascribed to the confined data about 
the dynamic assembly and interactions of such materials to create 
patterned and practical morphologies [100]. To combat such issues, 
the use of decellularized ECM (dECM) is currently receiving immense 
consideration as promising alternatives owing to their ability to 
preserve the complex functional and structural proteins of ECM 
[101]. Accordingly, a 3D cell-printed skin tissue utilizing skin-dECM 
(S-dECM) was presented by Cho’s group. As the porcine skin is highly 
similar to human skin, they successfully used decellularized porcine 
skin as a novel bioink, which contains intrinsic factors required for 
cell proliferation and showed that the new construct is highly stable 
for two weeks with a remarkable wound healing performance in vivo 
[101]. However, the contradiction between excellent 
biocompatibility with poor formability of dECMs limited their 
extensive applications. To overcome this challenge, a modified 
cryogenic free-form extrusion bioprinter was developed to directly 
print the simple decellularized small intestinal submucosa (dSIS) 
material extracted from porcine (Figure 2(a))[102]. Applying this 
approach, dSIS scaffolds with excellent physicochemical attributes 
and enhanced biocompatibility were fabricated. Owing to the similar 
chemical composition of dSIS with the components of dECM (mainly 
collagens and polysaccharides), this approach could open a new 
avenue for future studies.
Generally, there are two main attitudes concerning the skin EBB for 
wound treatment [103]: (1) in vitro bioprinting where the printed 
tissue is transplanted into the defect site and (2) in situ bioprinting 
where the bioinks are printed directly into the defect site. The 
feasibility of using bioprinting to fabricate skin constructs in vitro was 
first shown with multilayered engineered tissue composites of hFBs 
and hKCs deposited layer-by-layer within a collagen hydrogel, 
resulting in an inner layer of hFBs and an outer layer of hKCs [104]. 
To be more specific, a four-nozzle bioprinter developed utilizing 
pneumatic extrusion supported by micro valve control. Aiming to 
obtain multi-layered engineered composite tissues replicating 
natural skin layers, ten layers of collagen hydrogel precursor were 
deposited, in which human skin fibroblasts (hFBs) were printed in the 
second layer, and human keratinocytes (hKCs) were printed in the 
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eighth layer separately [104]. By applying a similar bioprinting device 
(but for deploying eight nozzles), a variable number of layers of cross-
linked collagen and collagen, including either hFBs or hKCs, were 
printed for expressing the epidermis, dermis, and dermal matrix of 
natural skin tissue. The printed tissue construct was comparable to 
human skin tissue biologically and morphologically and displayed 
better shape and form retention through in vitro cultures [105]. Kim 
et al. engineered a collagen scaffold that had notably good cellular 
behavior but poor mechanical stability regarding the extremely 
porous structure (> 95%) and poor mechanical characteristics of 
collagen [106]. To overcome this insufficiency, they produced a core 
(alginate)/ shell (collagen) scaffold which showed great structural 
stability, and optimum quantification of viable and proliferating hFBs 
and hKCs cells when cultured for 7 days’ duration (in vitro and in 
vivo). The developed construct also demonstrated an approximate 
Young’s modulus of 6.7 times to that of pure collagen, which mimics 
the skin modulus [107]. In a study reported by Cubo et al., fibrin-
based bilayer dermal constructs were fabricated utilizing human 
plasma and primary hFBs and hKCs taken from skin biopsies [108]. 
The histological and immuno-histochemical in vitro and in vivo 
analysis indicated that the 3D-bioprinted skin constructs exhibited a 
high degree of similarity to the native human skin. Kim et al. [109] 
used this method to fabricate collagen-based scaffolds with a poly(ε-
caprolactone) PCL mesh, to form the dermal component of a skin 
substitute. It was exhibited that incorporation of PCL mesh could 
stabilize the dermal matrix, and prevent collagen shrinkage during 
the maturation process. In a recent study, a thermosensitive poly (N-
isopropylacrylamide-co-acrylic acid) (p(NIPAAm-AA)) hydrogel was 
developed and implemented for various 3D printing methods (i.e, 
single nozzle and a single syringe, coaxial needles and double 
syringes, and a single nozzle and double syringes). Relatively high cell 
viability of keratinocytes, fibroblasts and endothelial cells was 
obtained through 3D printing of the cell-laden hybrid bioink 
(p(NIPAAm-AA) and fibrin). Also, superficial cornification of the 
epidermis layer, as well as sprouting and splitting of the 
subcutaneous endothelial cells, were inspected [110].
In comparison to the transplantation of in vitro fabricated constructs, 
in situ bioprinting avoids the risk of damaging the thin and fragile 
construct during transport and handling, and avoids potential issues 
related to the correct placement and orientation of a construct with 
complex 3D topology. In one of the first descriptions of in situ 
bioprinting, human keratinocytes and fibroblasts were printed 
directly into a full-thickness mouse skin-wound model [111]. Wounds 
were first scanned to obtain precise information on wound 
topography, which then guided the print heads to deposit specified 
materials and cell types in appropriate locations. The first layer of a 
fibrinogen–collagen hydrogel precursor containing fibroblasts was 
bioprinted, followed by the simultaneous deposition of thrombin to 
form a fibrin–collagen hydrogel. An additional layer of keratinocytes 
was then bioprinted on top of the fibroblast layer via a similar 
deposition approach. In studies by Skardal et al., amniotic-fluid-
derived stem cells were deposited on full-thickness skin wounds in 
mice, using either a fibrin–collagen bioink [112] or a hyaluronic acid 
(HA)-based gel with tuneable properties tailored for extended 
cytokine release [113]. The secretion of trophic factors accelerated 
wound-closure rates and promoted angiogenesis; however, the stem 
cells did not permanently integrate into the regenerated skin. The 
same approach was recently applied in a porcine model with large 
full-thickness wounds, where in situ bioprinting led to the complete 
re-epithelialization of the large wound after 8 weeks [114]. The main 
advantage of this approach is the rapid coverage of large wounds 
with permanent skin tissue, and its accelerated healing.
From the fabrication point of view, advanced approaches have been 
considered to satisfy the complex necessities of the skin tissues. 
Accordingly, hybrid bioprinting by integrating the advantages of EBB 
and other techniques has emerged as a new method to create 
scaffolds that mimic of targeted tissues [115]. In 2012, Leng et al. 
[116] developed a device consisted of a ten-layer microfluidic device 
with seven on-chip reservoirs that, in the following year, was applied 
to bioprint fibroblasts-laden hydrogel into wound dressings, which 
were subsequently implanted into murine wound models [117]. 
Hence, accurate spatio-temporal control over cell location and cell 
seeding was achieved, and the experiment result revealed enhanced 
wound healing, and keratinization was observed. In a remarkable 
report by Hakimi et al. [118] (from the same research group), this 
device was developed into a portable skin printer (weight < 0.8 kg) 
capable of being applied in swift repairing deep wounds. The study 
demonstrated the in situ production of skin sheets in the porcine and 
murine wound models as a direct therapy operating skin-specific 
cells in the bioink. The skin cell-laden sheets with controllable 
thickness, width, and composition were produced by incorporating 
dermal and epidermal cells into different cross-linkable hydrogels 
containing alginate or fibrin mixed with collagen and HA (Figure 2(b)) 
[118]. Such handheld 3D printers could be revolutionary in the 
prevailing healthcare market since patients do not have to wait for 
the laboratory-grown cellular skin grafts. Additionally, this 
technology could be utilized for emergency circumstances like burn 
trauma cases and be used for urgent treatment in real-time. As 
mentioned before, the preparation of electrospun fibers into 3D 
porous biomimetic scaffolds with accurately controllable shapes and 
large pores for tissue regeneration has attracted research attention 
[59,60]. Accordingly, 3D skin asymmetric (3D_SAC) constructs were 
produced using electrospinning and 3D bioprinting techniques [119]. 
A PCL and silk sericin blend was electrospun to produce a top layer 
aimed to mimic the epidermis features. In turn, the dermis like layer 
was formed by printing a chitosan/sodium alginate (SA) hydrogel. 
The results obtained in the in vitro assays revealed that the 3D_SAC 
display a morphology, porosity, mechanical properties, wettability, 
antimicrobial activity, and a cytotoxic profile that grants their 
application as a skin substitute during the healing process [119].
Over the past four decades, numerous researchers have performed 
many efforts in the design of human skin tissue though there are still 
shortcomings and challenges required to be overcome. Although the 
functionality of printed constructs can be improved through 
introducing more varieties of cells and cell numbers, there are still 
significant hurdles such as the formation of vascular networks, 
sensory receptors in addition to the proper development of hair 
follicles, pigmentation, and epidermis generation and maturation. 
Furthermore, the emerging organ-on-chip and microfluidic 
technologies can considerably assist in replicate as close as possible 
the heterogeneous cellular composition of native skin tissue. 
Bone
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Bone tissue as a dynamic structure is the main constituent of the 
musculoskeletal system, which its high mineralization of ECM makes 
it different from other connective tissues in rigidity and hardness 
[120]. The repair of bone tissue is a global clinical issue that has high 
morbidity in the trauma patients and imposes an enormous 
socioeconomic problem [121,122]. The gold standard for bone 
restoration still generally is autogenous bone grafts that are 
harvested from intra- or extra-oral sites; however, this has the 
limitation of low graft quantity, donor site morbidity, and infection. 
Although many researchers have made attempts to develop 
therapeutic approaches for the fabrication of human bone 
[121,123,124] as a highly ordered and vascularized tissue [125], few 
have succeeded in which there is still no effective treatment for most 
cases [126–128]. As a result, bone tissue engineering (BTE) 
undergoes a booming advancement as the alternative to bone 
grafting, where graft substitutes are made using biomaterials to 
replace or repair damaged bone defects [125]. Among different 
biomaterials, hydrogels are considered as promising materials for 
BTE due to their physical or structural similarity to natural tissues; 
however, hydrogels often suffer from poor mechanical properties 
specially in BTE applications [129]. By reviewing the available 
literature, it can be observed that some researchers have 
concentrated on the requirements for bioinks in 3D-printed bone 
scaffolds [121,123,130] . For instance, Turnbull and coworkers [131] 
critically focused on materials and barriers to clinical translation. 
They reported the ideal properties of bioactive composite 3D 
scaffolds and examined the recent use of polymers, hydrogels, 
metals, ceramics, and bio-glasses in BTE. In addition to the general 
characteristics of the bioinks in EBB, they should satisfy the 
specifications for bone tissue regeneration [132].
The challenge of using hydrogels for the fabrication of the 
musculoskeletal system via 3D bioprinting should be seriously 
considered since a stiff and coherent hydrogel-based construct 
would be required for implantation in the human body [133]. 
Accordingly, different strategies have been developed to enhance 
the strength of hydrogel-based bioprinted constructs, including 
utilizing toughened hydrogels and reinforcement of printed 
hydrogels with thermoplastic polymers [134–141] or bioceramics 
[142–145], nanofibers, nanoparticle [146–149], microparticles, and 
microcarriers [150,151]. Moreover, the crosslinking of bioprinted 
constructs by UV-rays and chemical agents does not only improve 
their mechanical properties, but it could also increase the stiffness, 
longevity, and thermal stability of 3D printed constructs 
[128,152,153]. Despite various attempts have been made to increase 
the stiffness of the hydrogel, few have succeeded. For instance, 
preculturing of cells in the constructs has been rejected because of 
being not economically and practically possible. Similarly, increasing 
the hydrogel cross-link density was declined due to the delaying new 
tissue formation by restriction of the nutrients and waste products 
diffusion within the highly cross-linked hydrogel system [144]. 
Scaffolds for BTE need to contain a mixture of macropores allowing 
cell and osteon ingrowth in vivo, and micropores to encourage cell-
scaffold ligand interactions [131]. Increased scaffold macroporosity 
has been shown to improve angiogenesis in vivo, whilst a degree of 
microporosity (pores with diameters lower than 10 µm) can improve 
cell-scaffold interactions, resulting in osteogenic effects. Gupta et al. 
[147] using gelatin/ carboxymethyl chitin/ HA produced a 
hierarchical 3D bioactive scaffold in a cryogenic environment 
followed with lyophilization. While the outer shape and 
macroporosity were controlled by the 3D printer, desirable rough 
surface morphology and the microporous structure were obtained 
through lyophilization. Their result showed that the incorporation of 
bulk and surface porosity could be lead to increasing the water 
uptake ratio, cell retention capability, cell infiltration, attachment, 
proliferation, (Alkaline phosphatase (ALP) level, and mineralization 
[147]. However, microvasculature as a major challenge in 
engineering large bone graft substitutes [154] is receiving 
considerable attention regarding that bone comprises of an 
extensive vascular system in the medullary cavity that infiltrates into 
the bone containing osteocytes within 100 μm distance. In traumatic 
injuries, necrosis of the blood vessels restricts the supply of nutrients 
and oxygen to the affected site, leading to tissue death [125]. The 
current strategy is to implant synthetic bone grafts, which often fail 
in the case of critical-sized defects as the peripheral vasculature does 
not reach the core of the construct. Therefore, the formation of 
congruent bone largely depends upon the development of a 
functional vascular system, which remains a big hurdle in the 
fabrication of human-scale construct [155,156]. Several convergent 
bioprinting strategies were used to handle this issue could be 
explained as follows: (1) multi-dispenser bioprinting with sacrificial 
materials or in combination with thermoplastic polymers, (2) coaxial 
bioprinting.
Applying sacrificial inks to create 3D vascular structures throughout 
thick bone constructs can increase nutrient diffusion into engineered 
bone graft substitute. Materials with reversible crosslinking 
mechanisms (e.g., Pluronic F127, polyvinyl alcohol (PVA), agarose, 
and gelatin) are often employed as the sacrificial bioink [131]. In such 
cases, the vascular network is fabricated through a fugitive bioink 
capable of being eliminated with suitable solvents or thermal 
modification resulting in a perfusable vasculature construct [125]. 
The origin of these scaffolds can be traced back to the work by 
Sawyer et al. [157] who scaled up a 3D thick perfused bone construct 
by printing cell-laden gelatin-methacryloyl (GelMA) with PVA as a 
sacrificial polymer. The construct was designed to have a central 
horizontal channel that supported a GelMA hydrogel laden with 
osteoblast-like cells. This study demonstrated the potential of using 
this technology to generate thick cell-laden constructs containing 
user-defined channels to aid the development of vascularized bone 
constructs [157]. In another example of employing multi-dispenser 
printing [158], a 3D cell-laden vascularized tissues integrated 
parenchyma, stroma, and endothelium into a single thick tissue 
bioprinted in a perfusion chip. They printed cell-laden inks composed 
of human bone marrow-derived mesenchymal stem cells (hBMSCs) 
and human neonatal dermal fibroblasts (hNDFs) within a customized 
ECM alongside embedded vasculature. It is subsequently seeded 
with human umbilical vein endothelial cells (HUVECs) in a 
crosslinking process to create a thick (1 cm) pervasive vascular 
network. Finally, it actively perfused with osteogenic media over 
more than six weeks. After 30 days, the printed hBMSCs expressed 
the highest osteocalcin expression in areas close to vessels perfused 
with osteogenic media. Collagen deposition was also found within 
printed filaments and around the circumference of the vasculature 
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and alizarin staining also revealed a high degree of mineralization 
within the tissue (Figure 3(a)) [158]. Byambaa and coworkers [159] 
designed a complex bone-like 3D vasculature structure by printing 
vascular endothelial growth factor (VEGF) functionalized GelMA 
bioink to fabricate bone and vascular tissues in one construct 
through a one-step bioprinting process [159]. The central fiber of the 
construct formed a perfusable blood vessel of 500 µm after 12 days 
of in vitro incubation. The results demonstrated that synthetic 
silicate nanoplatelets can trigger osteogenesis and also inducing the 
osteogenic differentiation of encapsulated human mesenchymal 
stem cells (hMSCs) within GelMA hydrogels. Furthermore, The 
approach of creating a central lumen using a composite GelMA-
nanoplatelet hydrogel not only indicates the creation of a 
mechanically stable construct but also shows the perfusion with 
growth media facilitated cell survival, proliferation, and osteogenic 
differentiation over 21 days [159]. In brief, prominent advances in 
the production of multiscale channels with high accuracy and 
suitable biocompatibility have improved sacrificial EBB of 
vascularized thick tissues. A broad range of channel sizes could be 
obtained based on the nozzle size and printability of bioink. Among 
various bioinks, thermosensitive polymers are so promising for 
printing cell-laden vascular constructs. However, the available 
literature suffers from the precise characterization of bioink 
combination and processing parameters such as pressure and light 
exposure on the biological characteristics of fabricated structures.
As earlier explained, coaxial bioprinting is an exciting approach to 
fabricate hybrid and vasculature structures [160]. The principal 
benefit of the core/shell construct is the potential of forming 
hierarchical, multi-layer tissue structures with desirable biological 
and mechanical attributes [161]. Raja and Yun [162] successfully 
provided bioprinted structures capable of homogeneous cell 
distribution along with performing a load-bearing function without 
breaking during tissue regeneration. It was the first simultaneous 3D 
printing of cells and bioceramics contains a core of α-TCP with a shell 
of alginate and pre-osteoblast bone cells. Accordingly, while the 
hydrogel shell prevents the immediate failure of the scaffold, even 
when the ceramic core was cracked, the construct showed greater 
mechanical stability than either brittle ceramics or weak hydrogels 
alone. Furthermore, data suggests that there is a direct connection 
between the shell thickness and mechanical properties in which the 
compressive modulus of each scaffold increased from 0.9 to 2.2 MPa 
with decreases in shell thickness from 150 to 75 μm (Figure 
3(b))[162]. As an innovative hybrid strategy, employment of the cell-
laden core with a stable shell was introduced to produce vasculature 
bone constructs [163]. Lee and Kim [163] developed a low-
temperature 3D bioprinting method improved with a microfluidic 
channel and core/shell nozzle to fabricate cells-laden constructs for 
the cryopreservation of a cell suspension. The cryopreserved scaffold 
exposed reasonable viability (~ 85%), proliferation, and ALP activities 
alike as the non-cryopreserved scaffold [163]. It should be noted that 
cryopreserve scaffolds have attracted considerable attention in TE 
since they can be considered ready-to-use “living” biomaterials, 
including a patient’s cells [164].
Following the hybrid bioprinting strategies, the combination of EBB 
and electrospinning has also been studied in TE of bone [165]. For 
instance, a 3D composite scaffold was made through infusing 
PCL/gelatin dispersed nanofibers into the meshes of the PCL 
construct [166]. According to the mechanical analysis outcomes, the 
compressive modulus of the scaffold (30.50 ± 0.82 MPa) was 
remarkably higher than that of the lyophilized electrospun scaffold 
(18.55 ± 0.56 MPa). Moreover, the microporous structure of the 
electrospun scaffold resulted in better cell proliferation and 
infiltration on the composite scaffold. In another study [167], a 
combined 3D printing system and electrospinning device was utilized 
to fabricate a 3D cell embedded scaffold constituted of 
perpendicular strands and a thin nanofiber sheet in the succeeding 
layer. The cell-laden alginate struts provided steady cell release to 
the layered nanofibers, resulting in a uniform cell distribution (Figure 
3(c)) [167].
Despite progress performed in bone bioprinting, various challenges 
face the fabrication of clinically appropriate, functional bone grafts. 
The principal hurdles are (1) construct stability, (2) restricted 
construct size, (3) vascularization, (4) lack of mechanical 
characteristics, (5) integration to native tissue and (6) long-term 
function. Clinical translation will demand the application of 
integrated bioprinting platforms allowing the employment of 
multiple biomaterials to create biomimetic constructs at a clinically 
applicable scale. Besides, multidisciplinary strategies and continued 
funding are required to realize accomplishment in this developing 
research area.
Cartilage
Cartilaginous tissue is an avascular and aneural structure, including 
an almost low density of chondrocytes and abundant water 
proportion (70%) [168]. It is a functional and very hydrated 
heterogeneous tissue for providing a low-friction, wear-resistant, 
and load-bearing surface in diarthrodial joints for an efficient joint 
move [36]. According to the ECM composition, cartilage tissue can 
be classified in three categories, including elastic cartilage (if elastic 
fibres are present in the ECM), fibrous cartilage (if the matrix is rich 
in collagenous fibres), and hyaline cartilage (if the matrix is mainly 
composed of glycosaminoglycans (GAGs)) [169]. From the 
microscopic point of view, human cartilage composed of a hydrated 
ECM, which is made of proteoglycans consisting of a core protein 
with covalently attached GAGs (accountable for the cartilages’ 
capacity to maintain high compressive loads), mainly chondroitin 
sulphates, and collagen type II fibrils (provide its high tensile strength 
and capability of tolerating shear stresses) [170,171]. 
Trauma, accidents, or other infections could cause cartilage loss, due 
to its disability to self-repair because of avascularity, the low 
proliferation rate of chondrocytes, and functional and structural 
complexity [172,173]. Despite existing various treatments for 
chondral injuries, including autologous chondrocyte implantation, 
periosteal grafts, mosaicplasty, and microfracture, clinical 
investigations failed to exhibit reliable generation of normal hyaline 
cartilage and long-term solutions [174–176]. Moreover, the 
generation of functional articular cartilage is challenging concerning 
the zonal structure of native tissue, including areas with different cell 
morphologies and arrangements, ECM arrangements, constituents, 
and distribution [177,178]. The introduction of 3D bioprinting in TE 
has attained prominent progress in simulating the anatomy of 
articular cartilage tissue [179], and among various dispensing 
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techniques, EBB is the most prevalent and affordable method 
[180,181]. Applying this particular technique, researchers have 
reported the production of cartilage-like constructs through the 
combination of various hydrogels [46,182–188]; However, the most 
efficient strategy has involved simultaneous deposition of 
thermoplastic polymers utilizing multi-dispenser systems while 
structural materials able of maintaining mechanical forces, and 
hydrogels as cell carriers [189–194]. Besides, researchers have 
endeavored to modify bioinks' attributes, such as printability, 
mechanical properties, and degradation rate [177,178,195,196].
For the generation of cartilage constructs, two main strategies of in 
vitro and in situ bioprinting have been considered in recent years. 
Employing the in vitro fabrication approach, chondrocytes ,which can 
be harvested from various zones of the cartilage [197], have been 
deposited in hydrogels (e.g., gelatin and alginate, alginate, cartilage-
dECM, and nanofibrillated cellulose) [198–202] with high cell viability 
and zone-specific patterns  [203,204]. Printing of human 
chondrocytes in a shear-thinning nanofibrillated cellulose can also be 
joined with cross-linkable alginate to fabricate anatomically formed 
cartilage constructs, with high accuracy and permanence [187]. 
Another approach includes the generation of constructs utilizing 
micromass chondrocyte pellets to make cartilage strands, with 
tubular penetrable alginate capsules serving as a repository for cell 
aggregation and tissue-strand maturation. This strategy resulted in 
~500 μm-diameter strands with notably enhanced cell density, also 
increased post-transplantation maturation and function of the 
printed tissue [205]. Combining varied cell types may also improve 
the effectiveness of the engineered cartilage [206]. In a research 
reported by Levato et al. [207], three materials were loaded for 
printing via multi-dispenser heads: (1) a superficial zone-mimicking 
bioink, consisting of articular cartilage-resident chondroprogenitor 
cell (ACPC)-laden GelMA, (2) a middle/deep zone-mimicking bioink, 
composed of bone marrow mesenchymal stromal cell (MSC)-laden 
GelMA, and (3) pluronic F-127 as sacrificial ink to support (MSC)-
laden GelMA during the process. The first seven layers and the last 
two were printed with the MSC-laden GelMA and ACPC-laden 
GelMA, respectively. The co-culture of cell types in multi-
compartment hydrogels allowed generating constructs with a 
layered distribution of collagens and glycosaminoglycans, defining 
cartilage with shallow and deep areas, each with distinguished 
cellular and ECM combination [207]. The combination of MSCs into a 
layered structure of natural and synthetic biomaterials can lead the 
cells to differentiate into zone-specific chondrocytes and producing 
native-like articular cartilage with mechanical and biochemical 
characteristics differing with depth [208,209]. Similarly, hyaline-like 
cartilaginous was created through the bioprinting of induced 
pluripotent stem cells (iPSCs) within a nanocellulose alginate bioink 
[210]. In another example of employing multi-dispenser bioprinting, 
Kesti et al. [211] fabricated cartilage grafts (i.e., 3D auricular, nasal, 
meniscal, and vertebral disk grafts) using a cartilage-specific bioink 
based on a blend of gellan, alginate, and a clinical product called 
BioCartilage (cartilage extracellular matrix particles). The MRI and 
histological evaluation after 8 weeks in vitro manifested that this 
bioink supports the proliferation of chondrocytes and effective 
deposition of cartilage matrix proteins (in the presence of 
transforming growth factor beta-3). Besides, it was revealed that a 
cation-loaded transient support polymer improves physical gelation 
for structure stabilizing [211]. Utilizing a similar approach, Kundu et 
al. [194] bioprinted cartilaginous tissue using PCL and chondrocyte 
cell-laden alginate. In vitro cell-based biochemical analysis was 
conducted to determine glycosaminoglycans (GAGs), DNA, and total 
collagen contents from different PCL–alginate gel constructs. PCL–
alginate gels, including transforming growth factor-b (TGFb), 
presented higher ECM formation. The histochemical and 
immunohistochemical analyses of the retrieved implants (after four 
weeks of implantation in the dorsal subcutaneous spaces of female 
nude mice) showed enhanced cartilage tissue and type II collagen 
fibril formation in the PCL–alginate gel (+TGFb) hybrid scaffold 
(Figure 4(a)) [194]. In 2016, Kang et al. [136] introduced an 
integrated tissue–organ printer (ITOP) for the reconstruction of ear 
cartilage tissue. The bioprinter was composed of multi-dispensing 
modules for delivering cells and various types of polymers. With the 
aim of facilitating the diffusion of nutrients to printed cells, the 
fabricated construct incorporated microchannels produced with the 
sacrificial molding of Pluronic1 F-127. To determine whether the 
printed ear constructs would mature in vivo, they were implanted in 
the dorsal subcutaneous space of athymic mice and were retrieved 1 
and 2 months after implantation. It was confirmed that the shape 
was well sustained, with considerable cartilage generation upon 
gross examination. Also, the histological analysis showed the 
formation of cartilage tissue (Figure 4(b)) [136]. In a recent study, a 
novel approach was presented by Chen and colleagues [212] for the 
fabrication of electrospun fiber-based scaffolds with accurately 
controlled 3D shapes and large pores, as well as fibrous surface 
morphologies similar to that of ECM, for cartilage regeneration. They 
processed gelatin/poly (lactic-co-glycolic acid) (PLGA) nanofibers into 
inks suitable for 3D printing, and then electrospun fiber-based inks 
were fabricated into printed constructs through combining 3D 
printing and freeze drying. The results exhibited good elasticity and 
water-induced shape memory, and scaffolds combined with 
chondrocytes attained satisfying cartilage regeneration in vivo 
(Figure 4(c)) [212].
Regarding the shortcomings due to the implantation of the 
prefabricated construct, the concept of in situ bioprinting of cartilage 
tissue was introduced by Cohen et al. [213]. Applying geometric 
feedback-based approaches, they fabricated 3D implants using 
alginate and chondrocytes for in situ repair of cartilage injuries. In 
another study, Li et al. [214] achieved the accurate size of defect 
regions of cartilage with the help of high-resolution 3D scanning and 
next applied in situ 3D bioprinting for injury rehabilitation ex-vivo. 
Succeeding, a handheld pneumatic extrusion device ‘‘Biopen” was 
designed by O’Connell et al. [215] concerning in vivo repair of 
osteochondral injuries. The novel nozzle design allowed the 
depositing of multiple inks in a collinear geometry. In vitro 
investigations revealed high viability (>97%) of human adipose stem 
cells in one-week post-printed hydrogels (GelMa + HAMa). 
Afterward, the same research group promoted Biopen via designing 
a co-axial nozzle that facilitated the simultaneous co-axial extrusion 
of bioscaffold and cultured cells directly into the cartilage defect in a 
single session in vivo surgery [216]. They tested Biopen to develop 
core/shell GelMa/HAMa bioscaffolds that have mechanical strength 
of 200 kPa and high cell viability (>90%) for chondral repair. The 
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results manifested that core/shell geometry preserves the cells from 
the printing process and damaging consequences of the free radicals 
produced by the photo-activation process. This handheld Biopen was 
also employed to study rehabilitation of full-thickness chondral 
defects in a sheep’s stifle joints which exhibited safety and potential 
clinical effectiveness [217]. The outcomes demonstrated that the in 
vivo 3D-printed bioscaffold bears better macroscopic and 
microscopic properties and shows an immediate configuration of 
hyaline-like cartilage. This study was significant as it was the primary 
in situ 3D bioprinting, which can be a key step toward the clinical 
employment of bioprinting technology.
In a recent study, the application of a robotic-assisted in situ 3D 
bioprinting technology for cartilage regeneration was reported. A 
bio-ink including hyaluronic acid methacrylate and acrylate-
terminated 4-armed polyethylene glycol was employed, and an in 
vitro experiment was conducted on a resin model. Also, to assess the 
cartilage treatment aptitude, the in vivo analysis was performed on 
rabbits. Based on the results, the osteochondral injury could be 
repaired as about 60 s, and the regenerated cartilage tissue exhibited 
the same biomechanical and biochemical performance in hydrogel 
implantation and in situ 3D bioprinting. It was observed that the 
presented method is very suitable for surgical procedure 
improvement, as well as enhancing cartilage rehabilitation [218].
Further improvements in 3D bioprinting will permit the production 
of patterns of growth factors, mechanical gradients, and stem cells 
in each zonal region of cartilage, enhancing the function of 
bioengineered cartilage tissue. It has been shown that 3D-printed 
cartilage can possess the histological and mechanical properties of 
human auricles after implantation in vivo [136].
Vascular
Vascularization plays a critical role in governing the regeneration of 
thick tissues like heart, liver, pancreas, kidney, and bone. It is 
required to provide oxygen and nutrients for cells and remove waste 
products out of tissue through a network [219,220]. Despite the 
significant advancement in traditional biofabrication methods, 
development of 3D vascular like network remains a big challenge in 
TE area. To address this issue, 3D bioprinting has been introduced as 
a promising approach to fabricate highly organized vascular 
structures within engineered tissue substitutes [221,222]. The main 
features in engineering vascular tissue are multi-scale and branched 
vasculature structure as well as proper mechanism of convective-
diffusive transport [223]. Bioprinting approaches for the fabrication 
of a vascularized tissue scaffold could be categorized into direct and 
indirect. Applying the direct strategy, lumen-containing strands 
would be fabricated within the scaffolds, while using the indirect 
approach, vascular networks would be formed within the scaffold 
through removing sacrificial strands [224].
Direct bioprinting of a vascular network, allows biopolymers or 
hydrogels to dispense in the form of strands to form scaffolds. To the 
best of the authors’ knowledge, EBB of hydrogels for vascular 
network formation has been firstly reported by Li et al. [225]. They 
developed a double-nozzle assembling method to fabricate a 
vascular like network with embedded hybrid hydrogels according to 
predesigned digital models for the creation of the liver-like 
constructs. Gelatin/alginate/fibrinogen encapsulated with adipose-
derived stromal cells (ADSC) and hepatocyte was used as bioinks. A 
solution of thrombin/CaCl2/Na5P3O10 was used to allow the sol-gel 
transition of gelatin and crosslinking of fibrinogen and alginate. After 
two weeks of cell culture, the hepatocytes performed some liver like 
metabolic functions and ADSC showed some endothelial-like cell 
properties, while construct maintained its integration. Application of 
multi-nozzle EBB in a vertical configuration for vascular 
reconstruction was later described by Tan et al. [226] who designed 
a tubular alginate constructs with 12 mm diameter and 15 mm 
length. In their work the crosslinking agent was provided through a 
concentric loop of 8 mm diameter. The quantifiable parameters such 
as tubular length, wall thickness and roundness have been proposed 
to characterize the quality of the printed materials. Creating more 
complex structures including branched tubes with large diameter is 
one of the important advances in EBB which was reported by 
Ghanizadeh et al. [227]. Besides this development, they used three 
stages crosslinking process to provide better printability, more 
rigidity after printing, and long term stability of alginate hydrogel in 
culture medium.
Coaxial nozzle assembling technique as a category of EBB has also 
been considered for 3D bioprinting of vascular networks. In a study 
by Zhang et al. [228], vessel-like cellular microfluidic channels were 
developed through coaxial 3D printing of the alginate hydrogels 
loaded with human umbilical vein smooth muscle cells (HUVSMCs) 
followed by a crosslinking process to form a hollow filament. The 
tubular filament was evaluated for their perfusion, permeability and 
cell viability. Regarding the application of artificial vascular network, 
the engineered constitute should possess desirable mechanical 
elasticity and strength for pulsatile stress and suture retention 
[220,229]. Mechanical properties of tubular constructs printed using 
a coaxial system has been proved to be improved by incorporation 
of carbon nanotubes (CNT) in a study by Dolati et al. [220]. They 
reinforced the alginate based conduits with CNT to enhance their 
mechanical properties and bioprintability. The results showed that 
tensile strength could be increased by ~ 1.5-2.1 times with different 
concentrations of fillers. Gao et al. [230] introduced a new 
configuration into the coaxial bioprinted conduits, with a Z-shape 
platform for layer-by-layer deposition of alginate hollow filaments to 
form a 3D structure with built-in microchannels. Using this method, 
a high strength structure could be obtained by applying a higher 
concentration of alginate and smaller distance between adjacent 
filaments. Moreover, the built-in microchannels resulted in higher 
cell viability. In a similar study by Attala et al. [231], a multi-layered 
structure of alginate hollow filaments with the complex geometry 
was fabricated using an open-source 3D printer with a custom-built 
microfluidic nozzle. With this system, a precise control of channel 
position, spacing, and diameter were possible. In another study, a 
coaxial EBB was used for the fabrication of cell laden vascular-like 
structures from blended hydrogel system of GelMA/SA/4-arm 
poly(ethylene glycol)-tetra-acrylate (PEGTA) [232]. Two different 
crosslinking systems including ionic crosslinking (by CaCl2 solution) 
and photocrosslinking were applied to obtain stable constructs. This 
blended hydrogel system demonstrated desired rheological 
properties and printability. Moreover, the 3D-printed constructs 
showed sufficient mechanical strength and biological properties. This 
work was further promoted by Pi et al. [233] such that a more 
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complicated hollow structure using GelMa-based bioinks was 
developed using a digitally tunable multi-layer coaxial nozzle 
printing. The GelMA/alginate hydrogel was printed in the form of 
circumferentially multi-layered hollow tissue construct, and eight-
arm poly (ethylene glycol) (PEG) acrylate with tripentaerythritol core 
(PEGOA) was used to improve the mechanical strength and stability 
of the deposited hydrogels.  Figure 5(a) represents the schematic 
illustration of the components of the multichannel coaxial extrusion 
system and cross-sectional views of the hollow structures. The figure 
also shows the walls of a single layered and a double-layered tube, 
colored fluorescently. Looking at the figure reveals that a wide range 
of cell types was tested for viability and proliferation which 
demonstrated favorable cell growth and maturation [233].
The ECM-related parameters such as deposition and alignment of 
collagen and elastin are crucial in vascular tissue engineering. 
Regarding this, creation a scaffold-based vascular substitute with 
small diameter and mechanical properties near to native vascular 
tissue still faces general and specific challenges. Additionally, 
applying scaffolds cause extra problems, such that mechanical 
strength of gels is naturally weak which may hinder the final strength 
of the tissue-engineered vascular like substitute. Also, 
biodegradation by-products of polymer can disrupt the normal 
organization of the vascular wall and even affect smooth muscle cell 
phenotype. Such issues caused the introduction and investigation 
the scaffolds-free bioprinting using cellular speriods based on self-
assembly approach [234]. In a study by Norotte et al, a fully biological 
engineered scaffold-free vascular substitute was developed using 
various vascular cell types. The cells were deposited simultaneously 
with agarose rode, used as molding template. The distinct cellular 
units were further fused to create single- and double-layered 
vascular tubular graft with small diameter (outer diameter: 0.9-2.5 
mm). The method was shown to be accurate, reliable, and scalable 
[235].
In a recent study, Zhou et al. [236] introduced a convenient and 
efficient technique, designated as the interfacial diffusion for 
creating vascular tissue graft. In this method, hydrogel material was 
extruded into another medium and subjected to a diffusion gelation 
process. Upon changing gelation time and nozzle size, the diameter 
of printed tubes was changed. In order to increase the tube 
resistance again internal pressures, bacterial cellulose nanofibers 
were loaded into the hydrogel system. The developed vascular graft 
was evaluated for in vitro and in vivo assay which demonstrated the 
mechanical stability of the graft in rabbit carotid artery replacement. 
Figure 5(c) illustrates the Schematic illustration of the inflammation-
mediated process for vascular remodeling and macroscopic 
observations of the vascular graft harvested after implantation for 1 
month. Moreover, the ultrasonography clearly shows the blood 
flows normally at a speed of 39.4 cm/s in the grafted vascular 1 day 
after the implantation [236].
Design and development of multi-level fluidic channels composed of 
macrochannel (for mechanical stimulation) and microchannel (for 
nutrient delivery) integrated into an organ on chip device were 
reported by Gao et al. [237]. They 3D-printed alginate hollow 
filaments loading L929 mouse fibroblasts and smooth muscle cells 
(SMCS) as separate layers over a rod. Figure 5(b) demonstrates the 
overview of the printed device of a single-layer structure with a 
length of 70 mm and a double-layer structure with a length of 60 mm 
and a longitudinal section of the single-layer structure. The 
developed structures showed relatively strong mechanical 
properties (due to the progressive crosslinking reaction) and high cell 
viability (91.4 % after 7 days of culture). A printed vessel-like 
structure containing three kinds of vascular cells is represented in 
Figure 5(b) [237]. In conventional EBB, surface tension and gravity 
influence the filament formation, morphology and diameter which 
may cause defects during 3D printing. Jin et al. [238] reported the 
application of yield stress support bath for decreasing the effects of 
surface tension and gravity on the filament formation. The 
alginate/gelatin blend as hydrogel precursor was printed in a 
Laponite nanoclay yield-stress bath. Their results demonstrated that 
nanoclay concentration significantly influences the morphology of 
the printed filaments. They further used this deposition approach for 
producing branched vascular like structures. The cell viability was 
shown to be around 90% after 3 days of culture. Indirect EBB was 
introduced to avoid some limitation of direct EBB including flowing 
of low viscosity hydrogels (such as alginate, collagen and fibrin) in 
contact with substrate or collapsing of printed layers. In this method, 
a slurry bath was applied in which nozzle can move around to print 
the ink without any resistance. After printing, the slurry can be 
removed by thermal or chemical means, while the solidified hydrogel 
forms the vascular pattern [224]. This method is also applicable in 
creating channel inside the bulk hydrogels. In this case, the printed 
tubes are removed from the hydrogels to form the channels 
embedded hydrogels [239,240]. Using this approach, Bertassoni et al 
reported a 3D micromolding method utilizing agarose fibers as a 
permissive template to create perfusable microchannel network 
inside GelMA (gelatin methacryloyl) hydrogels [241]. Their results 
indicated that fabricated microchannels embedded hydrogels 
showed enhanced mass transport, cell viability (more than 90%) and 
differentiation.
Application of sacrificial moulding to produce rigid lattices of 
filaments using 3D bioprinting was reported by Eltaher et al. [242]. 
They described the development of high-resolution structures based 
on flexible sugar-protein composite by casting during 3D printing to 
form sacrificial vessels. The thin endothelialized vessel walls were 
created by the incorporation of biocompatible crosslinkers. 
Moreover, it was demonstrated that perfused vascular channels 
sustain the metabolic function of primary human cells. In a very 
recent work by Liang et al. [243], a non-sacrificial gel system 
containing sacrificial borate ester hydrogel was prepared to create 
tubular microchannels. In this hydrogel system, N-
isopropylacrylamide, pentafluorophenyl acrylate, poly(vinyl alcohol), 
and cellulose nanofibrils were applied for thermoresponsiveness, 
post-modification, gel formation and 3D printing facilitation, 
respectively. To obtain 3D vascularized constructs, the non-sacrificial 
gel was cast on the sacrificial printed hydrogel following by the 
immersion into the culture medium, which resulted in creating 
interconnecting multichannel in 5 min. The developed constructs 
exhibited vascular endothelial cells proliferation.
Biofabrication of living tissues and organs considerably relies on the 
vascularization. Despite the great advancement in common 
biofabrication approaches, creating a hierarchical perfusable 
vascular network with anatomical exactitude, and heterocellular 
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structure remains the main challenge. To date, significant progress 
has been made on generating perfusable branched vascular network 
and vascularized tissue; however, much effort must be made in 
fabricating small-diameter vascular graft with complex 
microarchitecture and fully biological functions. Moreover, 
employing new bioinks based on functionalizing synthetic 
biomaterials, dECM, and autologous cells will result in clinically 
derived development in vascularized tissue substitutes. Further, the 
engineered materials should possess superior mechanical properties 
such as elasticity, similar to native vascular tissue.
Neural
The regeneration of nerve defects/damages such as acute traumatic 
injuries (including brain injuries and spinal cord injuries) and 
neurological diseases (including stroke, Alzheimer disease, Parkinson 
disease, multiple sclerosis, and Huntington’s disease) is one of the 
most challenging clinical issues worldwide [244,245]. Development 
of nerve 3D models mimicking the native ECM has been emerged as 
one of the promising strategies to reconstruct defected nervous 
tissues. Generally, the neural model should possess specific 
requirements including: neurocompatibility to allow attachment and 
proliferation of nerve cells, elastic properties/hierarchical 
microarchitecture to mimicking the mechanical/physicochemical 
features of native nervous tissues ECM, and ability to 
electrocunductivity [246]. Among all 3D bioprinting methods, EBB in 
particular showed advantages in developing neural tissue models 
due to its compatibility with processing the broad range of materials 
set, including cell suspensions, cell-laden hydrogels, solutions, 
thermoplastics, thermosets, elastomers [247]. Lack of appropriate 
neural bioinks which can properly mimic the mechano/chemical 
characteristics of native ECM is one reason for relatively fewer 
available reports on the application of EBB in neural regeneration. In 
a recent study by Haring et al. [248], a filler free bioinks was 
developed. This bioink was made by crosslinking of thiolated Pluronic 
F-127 with dopamine-conjugated gelatin and dopamine-conjugated 
HA through a thiol/catechol reaction. The Schwann cell-, rodent 
neuronal cell-, and human glioma cell encapsulated bioink was 
subjected to form neural constructs. In another work on designing 
suitable bioink that possesses proper mechanical properties while 
promoting cell proliferation and tissue formation, Hsiao et al. [249], 
synthesized dual stimuli-responsive biodegradable polyurethane 
hydrogel. The advantage of the developed hydrogels bioink was its 
relatively low viscosity that could avoid excessive fluid shear stress 
and potential for jamming during extrusion. Moreover, the proper 
structure strength and shear yield stress of the hydrogels could bear 
the weight of ink without obviously changing the shape of stacking 
fibers. Their results also demonstrated that the printed constructs 
were conductive to proliferate and growth of NSCs as well as their 
differentiation into neural cells.
The first attempt in biofabrication of a fully cellular nerve graft 
composed exclusively of cells and cell secreted material was 
reported by Owens et al. [250]. The mouse bone marrow stem cells 
and Schwann cells were printed in an agarose mould following by the 
removal of the mould after 7 days. The developed graft was 
successfully implanted into the rats suffering from sciatic nerve injury 
and tested for both motor and sensory function. Lozano et al. [251] 
utilized a handheld reactive bathless 3D printer to develop brain-like 
structures made of discrete layers of neural cells encapsulated in 
arginine-glycine-aspartate (RGD) peptide modified gellan gum 
hydrogels. Primary cortical neurons and glial cells successfully were 
encapsulated in the 3D-printed hydrogel, and showed higher survival 
and networking of cells in RGD-coupled gellan gum than pure gellan 
gum. Figure 6(a) depicts the schematic representations of brain layer 
structures and cortical neurons encapsulated in RGD-gellan gum 
after 5 days of culture [251].
The 3D bioprinting was applied to develop spatial cell culture system, 
in which the 3D-printed sub-millimetric hollow alginate spheres, 
encapsulating with neuronal stem cells (NSC) and coated internally 
with Matrigel (a layer of ECM) of a few microns thick, were generated 
[252]. Utilizing a coaxial flow device, a multi-layered jet from alginate 
hydrogel was formed. The inner wall of the capsules was shown to 
be decorated with a Matrigel layer anchored to the alginate hydrogel 
mimicking the basal membrane of cellular niche. Figure 6(b) exhibits 
schematic illustration of the neuronal capsule. The developed 3D-
printed microfluidic device was able to differentiate cells into the 
neurons within the hydrogel, while maintaining the cell viability. The 
DAPI staining of the cells nuclei and tubulin subunit Beta3 staining of 
mature neuritis are illustrated in Figure 6(b) [252]. Coaxial EBB was 
also used in another study to produce cell-encapsulated hydrogel 
structures and core–shell cell fibers as cell-laden frameworks in 
regeneration of neural tissue. In that study, SA was used as bioink to 
encapsulate mouse neural progenitor cells. In cell-encapsulated 
structures, cells were separated, while in cell fibers they are directly 
connected. Cells also showed stronger tendency to differentiation in 
cell fibers compared to another investigated structure [253].
As discussed earlier, one of the main applications of 3D printing is 
creating cell-based tissue constructs. In this regard, the first work on 
direct-write printing of hNSC encapsulated hydrogel to fabricate a 3D 
neural mini-tissue construct was reported by Gu et al. [254]. They 
applied a micro-EBB to print a cell encapsulated alginate/ agarose/ 
carboxymethyle cellulose-based construct. The cells showed 
desirable viability, differentiation into functional neurones, as well as 
formation of synaptic contacts and networks. Moreover, calcium 
imaging together with scanning electron microscope (SEM) imaging 
of neurons and neuritis revealed that the cells can reasonably model 
the form and activity of human neural cells. Similarly, Joung et al. 
[255] developed a 3D-printed neural tissue constructs in the shape 
of spinal cord containing neuronal progenitor cells (NPCs) and 
oligodendrocyte progenitor cells (OPCs) using a one-pot printing 
process. Figure 6(c) illustrates the schematic of the spinal cord 
designed for a 3D-bioprinted multichannel scaffold modeling along 
with a schematic overview of the 3D bioprinting process. The 3D 
scaffold was fabricated through the sequential deposition of multiple 
cell laden bioink (cell containing Matrigel matrix, gelatin/fibrin, 
GelMa) and scaffold ink (poly (ethylene glycol) diacrylate, alginate, 
and methylcellulose) in a layer by layer manner to create multiple 
channels. This work was the first attempt of 3D printing neuronal 
progenitor cells with differentiation into axon propagating. The 
printed construct showed cellular viability which maintained cell 
specific phenotype properties in response to the printed 
microenvironment, which the cell scaffold interactions are given in 
Figure 6(c) as neural marker expression [255].
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To date, numerous researches have been devoted to designing 
biomimetic constructs for nerve tissue engineering via integration of 
multiscale micro- and macroenvironment. Accordingly, a very recent 
study presented a 3D bioprinted scaffolds based on GelMA/Chitosan 
Microspheres prepared through a microfluidic system. Cell-scaffolds 
interaction was studied by co-culturing PC12 and Schwann cells 
[256]. The results designated that such multiscale composite 
structure with hydrogel microspheres gave a decent 3D 
microenvironment for neurite growth enhancement, and the 3D 
printed hydrogel network provided a 3D macroenvironment 
resembling the epineurium layer for Schwann cells proliferation and 
nerve cell arrangement [256].
In summary, although successful fabrication of the engineered nerve 
constructs achieved through multiple-dispensers and coaxial 
extrusion bioprintings, future advances in materials will likely enable 
more flexibility to cell compatibility and adhesion while retaining 
printability. Furthermore, it seems that Four-dimensional (4D) 
printing [257,258] is also gaining attention as an emerging method 
for obtaining external stimuli-responsive constructs and overcome 
some limitations of 3D bioprinting technologies in creating high-
resolution constructs.
Muscular
Approximately half of the human body’s weight is muscle. It is the 
only tissue in the body that can contract, or shorten, so all body 
movements include muscle of some kind [259]. In the muscular 
system, muscle tissue is classified into three primary types, i.e., 
skeletal, cardiac, and smooth, with a unique structure and a 
particular role [260]. The 3D bioprinting has made exceptional 
progress in versatile fields, which also provides an innovative 
approach in muscle TE. Reviewing the literature, it can be observed 
that the researchers worldwide investigated the regeneration of 
muscle tissues within the context of hydrogel-based EBB.
Skeletal Muscle
Serving about 45% of the human body weight including over 600 
various types, skeletal muscles involved in skeletal support, stability, 
movement, and even in the regulation of metabolism [261,262]. 
Skeletal muscle TE (SMTE) intends to develop functional skeletal 
muscle constructs [263,264] to replace or to restore damaged 
tissues, represent as in vitro models for comprehending the growth 
mechanisms of the muscular system, and for examining different 
drugs for the remedy of ‘muscular injuries and illnesses [265,266]. 
Human skeletal muscle is composed of complex anatomical 
structures, including uniaxially ordered myotubes and widely 
distributed blood capillaries. Accordingly, vascularization is a crucial 
part of the successful development of engineered skeletal muscle 
tissue [107]. Despite significant advances in SMTE using various 
conventional methods, the forces generated of engineered skeletal 
muscle tissues are yet low compared to their natural counterparts, 
and lack of accurate 3D spatial cell organization [267–269]. 
Mimicking extremely packed and arranged cellular structure of the 
native muscle tissue, employing natural or synthetic scaffolds and 
microscale technologies, is essential for the successful SMTE 
[270,271]. The 3D bioprinting has emerged as a powerful microscale 
technology for SMTE [272,273].
Hydrogels containing muscle precursor cells have been widely used 
as bioinks in combination with support structures in thermoplastic 
polymers [274,275] and/or sacrificial materials [136,276–278] to 
attain proper arrangement of cell-laden fibers capable of mimicking 
the native muscle tissue [264]. Different studies have investigated 
the propriety of GelMA hydrogel and its composites with various 
nanomaterials for SMTE [72,265,279,280]. Some solutions have been 
proposed to provide high cellular viability and function of skeletal 
muscle cells, such as applying optimized alginate concentration 
combined with a suitable crosslinking method [272,281]. The 
administration of growth factors (locally or systemically) has also 
presented a great promise to stimulate angiogenesis, stem cell 
recruitment and differentiation, cell survival and proliferation, a 
decrease of apoptosis, and adaptive remodeling [282,283]. Normally 
releasing a single factor is expensive, yet possible results in disease 
transmission or infection are principal limitations of this approach. It 
has been demonstrated that platelet-rich plasma (PRP) could address 
these challenges by releasing biologically active proteins and growth 
factors over several days as a remedy for musculoskeletal diseases 
[284]. For instance, a patient-specific bioink been generated via 
loading an alginate bioink with PRP for angiogenesis enhancement, 
inflammation reduction, stem cell recruitment, and cardiovascular 
and skeletal muscle tissue regeneration [285].
Skeletal muscle tissue has a complex multicellular anisotropic 
structure concerning the nervous and vascular networks. Such 
complexity can be achieved through the use of more complicated 
bioprinting processes combining various techniques, bioinks, and cell 
types [286,287]. Moreover, the gelled bioink should have similar 
mechanical characteristics to that of skeletal muscle tissue. Although 
hydrogel-based 3D engineered muscles, dECM scaffolds, and 
acellular biological scaffolds have been widely investigated for the 
volumetric muscle loss (VML) treatment [288,289], they have shown 
limited efficacy. Accordingly, Choi et al. [290] proposed a novel VML 
treatment using a tissue-derived bioink for bioprinting of 
vascularized volumetric muscle constructs. Human skeletal muscle 
cells (hSKMs) and human umbilical vein endothelial cells (HUVECs) 
were blended in skeletal muscle dECM (mdECM) and vascular dECM 
(vdECM) bioinks, respectively, for coaxial bioprinting of them into 
thick constructs. The prevascularized muscle constructs exhibited 
enhanced cell viability without generating hypoxia, myotube 
formation, and de novo myofiber regeneration in a VML rat model. 
In vivo outcomes revealed that coaxial nozzle printing mimicked the 
hierarchical structure of vascularized muscles, and allogeneic human 
cells in the constructs increased vascularization, innervation, and 
also 85% of functional recovery witnessed in VML injury [290]. But, 
due to the low mechanical properties of gels made by dECM-based 
bioinks, it may require stiffening utilizing crosslinking agents, or 
blending with different components [48,291]. Despite promising 
outcomes, the disadvantages of dECM-based bioinks are the batch-
to-batch variability and the possible immune responses they may 
induce in vivo upon implantation [273].
Reviewing the available literature revealed that despite notable 
advances in SMTE through bioprinting, the level of organization of 
differentiated muscle precursor cells—i.e., the arrangement of 
sarcomeres, the production of long-range multinucleated myotubes 
and degree of their alignment—was limited, most probably due to 
substrate mechanical characteristics and matrix density issues 
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[273,292]. A strategy that is growing consists of employing the 
advantages of EBB combined with other scaffold fabrication 
technologies, to construct advanced structures that mimic skeletal 
muscle tissue. 
In 2015, lee and colleagues [275] introduced a novel method for the 
3D biofabrication of complex structures based on multi-dispenser 
bioprinting. Employing the 3D integrated organ printing (IOP) 
system, C2C12 cell-laden hydrogel-based bioink was co-printed with 
polyurethane (PU) on one side, NIH/3T3 cell-laden hydrogel-based 
bioink was co-printed with PCL on the other side for elasticity and 
muscle development, and stiffness and tendon development, 
respectively. The results demonstrated the versatility of the IOP 
system to fabricate complex tissues such as the musculoskeletal 
system, which have regional diversity in cell types and mechanical 
characteristics [275]. They promoted the system and presented the 
ITOP system capable of fabricating stable, human-scale tissue 
scaffolds of any shape, and providing microchannels with a porous 
lattice pattern that promoted nutrient and oxygen diffusion into the 
printed tissue scaffolds in which resulted in enhanced tissue 
formation. Applying the ITOP, they fabricated organized skeletal 
muscle constructs (15 × 5 × 1 mm3) which eventually were implanted 
subcutaneously in athymic nude rats. The outcomes demonstrated 
evidence of vascularization without necrosis and anew formed 
oriented myofiber bundles [136]. In the following, they extended 
their strategy to treat the muscle defect injuries utilizing the human 
cell-laden skeletal muscle constructs. Accordingly, 3D skeletal muscle 
constructs (up to 15 × 15 × 15 mm3) were fabricated that maintained 
long parallel multi-layered bundles of densely packed, extremely 
viable, and aligned myofibers [293]. In vivo study in a rodent model 
of tibialis anterior (TA) muscle defect after 8 weeks of post-
implantation showed 82% of functional rehabilitation. Besides, 
histological and immunohistological analyses designated that the 
effective integration of bioprinted constructs with host vascular and 
neural networks. The results confirmed the potential application of 
the 3D-bioprinted skeletal muscle with a spatially organized 
structure in reconstructing the extensive muscle injuries [293].
Inspired by the native structural morphology of skeletal muscles, 
Costantini et al. [294] introduced an innovative hybrid 3D bioprinting 
approach to fabricate skeletal muscle tissue with functional 
morphologies. The technique was based on a microfluidic printing 
head linked to a co-axial needle extruder for high-resolution 3D 
bioprinting of aligned hydrogel fibers encapsulating muscle 
precursor cells (C2C12). The muscle myofibers exhibited sarcomeric 
organization and improved muscle regeneration in 
immunocompromised mice models. Applying such an approach 
could lead to an enhanced myogenic differentiation with the 
formation of parallel aligned, long-range, and tightly packed, 
myotube, hence mimicking the natural tissue morphology and 
organization more intimately. More recently, Testa et al. [295] used 
the same approach and printed human muscle cells obtained from 
perivascular and pericyte stem cells to operate sphincter muscle 
injuries. The results of a pre-clinic study confirmed the feasibility of 
their innovative approach to treating the forms of fecal incontinence 
that are unresponsive to conservative therapies.
As a novel research line, Kim and colleagues have focused on the 3D 
fabrication of a group of muscle fibers forming a fascicle via EBB 
conjoined with electrospinning [296–300]. They proposed a new cell-
laden scaffold, including macro-sized struts for providing a 3D 
structural shape, aligned nanofibers, and cell- printed myoblasts. The 
results showed higher sarcomeric formation and differentiation on 
the seventh day of culture on collagen-coated aligned fibers and 
aligned fiber constructs in comparison with random fiber scaffolds. 
Besides, the incorporation of micro/nanofibers in the hierarchical 
scaffold significantly influenced myoblast proliferation, alignment, 
and even promoted the creation of myotubes [296,297]. In another 
example of the biomimetic muscle bundle fabrication, analysis of 
cells exhibited longitudinal cell alignment, high cell infiltration 
between the microfibers, excellent cell proliferation on the surface, 
and resulted in a construct mimicking a muscle bundle section [298]. 
Based on this initial success, they have recently studied the 
application of this platform for co-culturing HUVECs and C2C12 cells 
[300]. To be more specific, HUVECs-laden alginate bioink was 
uniaxially electrospun on the surface of PCL and collagen struts as 
mechanical supporters by a topographical cue. The electrospun 
HUVECs exhibited high cell viability (90%), homogeneous cell 
distribution, and effective HUVEC growth. Moreover, the myoblasts, 
which were seeded on the vascularized structure (HUVECs-laden 
fibers), were co-cultured to help myoblast regeneration. In 
comparison to the scaffold that comprised only myoblasts, the 
construct that included myoblasts and HUVECs expressed a high 
degree of the myosin heavy chain (MHC) with striated patterns and 
improved myogenic-specific gene expressions (Figure 7(c)) [300]. 
Their research has opened a new avenue for combining a novel 
scaffold design with an innovative cell-printing method to obtain 
myogenic tissue rehabilitation. In a recent study, Kim et al. [301] 
investigated  the probability of using the bioprinted human skeletal 
muscle scaffolds with neural cell integration to enhance the 
structural and functional regeneration of extensive muscle defect 
injuries. Neural input into the bioprinted skeletal muscle construct 
demonstrated the development of myofiber formation, long-term 
durability, and neuromuscular junction generation in vitro. 
Moreover, the bioprinted neural cell-laden human skeletal muscle 
scaffolds promoted rapid innervation and developed into organized 
muscle tissue that reconstructed normal muscle weight and function 
in a rat model of tibialis anterior (TA) muscle defect injury. The results 
showed that the 3D bioprinted human neural-skeletal muscle 
scaffolds could be quickly combined with the host neural network, 
following in accelerated muscle function rehabilitation [301].
Despite significant progress, the bioprinting of thick skeletal muscle 
tissue is still challenging concerning the need for an integrated 
vascular network. Besides, further improvements are necessitated, 
such as cells derived from patients, iPS cells, and stem cells, which 
will facilitate the development of patient-specific implants [302].
Cardiac muscle
Most heart failures manifest cardiomyocyte loss, which is irreversible 
and leads to lethal heart diseases and high mortality rates [303]. 
Currently, heart transplantation is the best choice at the end-stage 
of heart failure; though, substituting the damaged heart with a 
healthy one faces various limitations, such as insufficient organ 
availability, immune rejection, and surgical complexities [304]. 
Accordingly, strategies to promote heart rehabilitation, notably 
through TE principles, have attained growing attention [305]. 
Although bioengineering of a functional cardiac muscle constituted 
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of primary cardiomyocytes (CMs) is a promising approach for 
myocardial regeneration, its applications remain restricted 
concerning that the cardiac tissue is an extremely organized 
structure with individual physiological, biomechanical, and electrical 
properties [306]. Bioengineering cardiac tissue via bioprinting 
technology as a viable option for creating functional tissue constructs 
is gaining increasing importance owing to its complex build-up 
capability [307,308].
The 3D bioprinting has been adopted to produce cardiac patches that 
contain both cells and ECM proteins [281,292,309,310]. Reviewing 
the literature, despite the origins of the base materials, hydrogels 
remain to be desirable materials for cardiac tissue regeneration 
[311]. In some studies, a single ink and material formulation have 
been produced and applied using conventional bioprinting [312–
314]. For example, a porous patch was printed to support cell 
attachment and CM differentiation, and enhance left ventricular 
remodeling in mice by incorporating cardiac-derived progenitor cells 
into a gelatin/ HA gel [314]. Concerning the need for more complex 
tissues and the limitation of the available approaches, the 
researchers came up with the idea of hybrid structures generated 
using multiple-dispenser bioprinting and composite bioinks. 
Following this idea, Jang et al. [315] reported the development of 
pre-vascularized and functional disk-shape constructs utilizing stem 
cell-laden dECM bioinks. In their research, multiple cell types were 
consolidated into dECM bioinks, plus soluble factors such as VEGF, to 
form composite 3D-printed patches. The printed structure composed 
of spatial patterning of dual stem cells (i.e., human cardiac progenitor 
cells (hCPCs) and human turbinate tissue-derived MSCs (hTMSCs)) 
improves cell-to-cell interactions and differentiation capability and 
functionality for tissue regeneration. The developed patterned patch 
promoted vascularization and tissue matrix formation in vivo and 
exhibited enhanced cardiac functions, reduced cardiac hypertrophy, 
and fibrosis, increased migration from patch to the infarct zone, as 
well as advancements in cardiac functions. This method presented 
the spatial patterning of cells in a form that is in favor of rapid 
vascularization. Hence, bioprinted stem cell patches were shown to 
be a promising therapeutic approach for ischemic heart diseases 
[315]. In another study, fabrication of contractile cardiac tissue 
construct utilizing three dispensing modules was reported by Wang 
et al. [308]. They printed primary CMs incorporated in a fibrin-based 
bioink (including gelatin and HA) along with a sacrificial hydrogel and 
supporting polymeric frame (PCL). Fabricated constructs had a 
spontaneous synchronized contraction in culture, indicating in vitro 
cardiac tissue construction and maturation. Progressive cardiac 
tissue development was approved after one week of culture, and 
cardiac tissues were developed with uniformly aligned, dense, and 
electromechanically coupled cardiac cells following three weeks 
[308].
Recapitulating the complexity of myocardium within functional 
constructs with tailored biological and mechanical attributes is one 
of the current scientific preferences in the field of TE, which has 
stimulated researchers to design hybrid bioprinting methods. As a 
novel hybrid strategy, Zhang et al. [316] fabricated endothelialized 
human myocardium employing coaxial bioprinting combined with a 
microfluidic perfusion bioreactor. The constructs were fabricated 
using a composite bioink, including GelMA, alginate, and induced 
iPSCs, and next seeded with CMs to induce the myocardium 
development. Although the bioprinted microfibrous structures in 
this work were not perfusable, it was observed that the printed 
endothelialized microfibrous scaffold was capable of spontaneous 
and synchronous contraction [316]. Following the hybrid bioprinting 
strategy, Maiullari et al. [317] presented the fabrication of functional 
heart tissue with simultaneous bioprinting of iPSC-derived 
cardiomyocytes and HUVEC cells via applying microfluidic printing 
head (MPH) coupled to a co-axial nozzle extruder. It was the first 
research that exposed vasculature development in transplanted 
tissue via printed endothelial cells. The resultant construct was 
better adapted for integration with the host’s vasculature due to its 
combination of iPSC-CM with a high orientation index and HUVEC 
originated blood vessel-like shapes. Moreover, they showed the 
capability of multi-cellular bioprinted constructs to mature in 
vascularized functional tissues in vivo, which can be used in different 
translational applications [317] (Figure 7(a)) [317]. Izadifar and 
colleagues [318] utilized a UV-integrated pneumatic 3D-Bioplotter 
system to construct human coronary artery endothelial cells 
(HCAECs) encapsulated in methacrylated collagen (MeCol). The CNT 
was incorporated into alginate and MeCol bioink for building cardiac 
patch with electrical and  mechanical attributes. As a result, HCAECs 
in MeCol gel presented significant cellular proliferation, migration, 
and differentiation over 10 days of incubation in in vitro cell culture 
[318].
Despite meaningful advancements, the production of thick 
vascularized tissues that entirely match the case remains a challenge 
in cardiac TE. Lately, Dvir and colleagues [319] fabricated 3D 
cellularized, vascularized, thick, and perfusable cardiac patches for 
the first time, which have demonstrated to be a breakthrough in 
transplant science. They have exhibited bioprinting of fully 
personalized contracting cardiac patches utilizing patient’s cells, 
which decreases the risk of an immune response. Accordingly, they 
combined a personalized hydrogel, which was derived from the 
processing of ECM obtained through biopsy of fatty tissue with the 
patient’s cells (iPSC-derived CMs). The engineered cells in the 
fabricated cardiac patch were elongated and aligned, with massive 
striation, which showed their contractile capacity. Consequently, 
they demonstrated free-form printing of volumetric and 
anatomically heterogeneous−cellularized human hearts with major 
blood vessels (Figure 7(b)) [319]. Although the printed patches could 
thoroughly match the anatomical, cellular, biochemical, and 
immunological characteristics of the patient, the printed blood vessel 
network is still limited and requires further investigation. To address 
this challenge, advanced technologies to accurately print small-
diameter blood vessels within thick structures should be developed.
Smooth Muscle
As a vital regulator of organ function, smooth muscle is an 
involuntary non-striated muscle in the walls of hollow organs like the 
bladder, uterus, stomach, intestines, and the walls of passageways, 
such as the arteries and veins of the circulatory system [320]. 
Aberrant smooth muscle contraction represents a significant role in 
the pathology of a broad range of diseases. For instance, although 
asthma, COPD, and Crohn's illness are inflammatory in nature, each 
of them is characterized by changes to normal smooth muscle 
contraction [321,322]. Despite significant efforts, research applying 
conventional 2D in vitro methods and animal models has failed to 
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find a cure for the mentioned disorders of aberrant contraction 
[323,324], which resulted in the development of in vitro technologies 
(e.g., 3D bioprinting). With the aim of enhancement in the relevance 
of in vitro models for human illness, Dickman et al. investigated the 
efficacy of a unique microfluidic 3D bioprinting technology to 
generate viable and contractile smooth muscle tissue. Primary 
human airway and SMCs were printed into rings of muscle tissue in 
high density and viability. Based on the results, in response to 
physiologically relevant contractile agonists and clinically proven 
pharmacological triggers of relaxation, printed tissues regenerated 
the acute contractile function of smooth muscle. Utilizing an 
identified trigger of fibrosis (TGFβ) in airway muscle rings induced 
long-term alterations in tissue function similar to that seen in chronic 
lung infections. Furthermore, combining dECM into intestinal 
smooth muscle constructs promotes contractile function relevant to 
a standard collagen-based hydrogel [325].
The ability to fabricate perfusable, small-diameter vasculature is a 
foundational step toward generating human tissues/organs for 
clinical applications. Cell-laden perusable vascular conduits have 
been fabricated for employment in thick tissue regeneration. 
Employing a coaxial printing system, Zhang et al. developed 
branched vascular conduits using SA [326]. It has been shown that 
HUVSMCs encapsulated in SA maintain their functions after printing. 
In another study, to replicate the cellular composition of natural 
blood vessels, HUVECs and MSCs were incorporated into a bioink 
comprised of GelMA, SA and PEGTA which further differentiated into 
vascular SMCs in the presence of transforming growth factor-β1 
[232]. Artificial valve conduits made from SMCs and aortic valve 
leaflet interstitial cells (VIC) have been fabricated and implemented 
to displace traditional prosthetic substitutes for the cure of heart 
valve illness [220,327]. The alpha-smooth muscle actin and vimentin 
secreted by the printed cells showed the potential of EBB to produce 
valve-like tissue constructs [327]. Similarly, constructs with high 
viability and the required function of hepatocytes have also been 
printed, confirming the capability of EBB techniques for 
rehabilitation of human liver function [328].
Despite advances, it is very challenging to create vasculature 
integrated with smooth muscle and endothelium that mimic the 
complexity and functionality of natural vessels. Recently, an 
innovative method for coaxial extrusion printing self-standing, small-
diameter vasculature with smooth muscle and endothelium was 
performed within combining tailored mussel-inspired bioink and 
novel “fugitive-migration” approach, and its usefulness and 
satisfaction over other techniques were manifested. The outcomes 
exhibited the bioprinted vascular construct possessed numerously 
desirable, biomimetic properties such as proper biomechanics, 
higher tissue affinity, vascularized tissue formation capacity, 
practical perfusability and permeability, and in vivo autonomous 
connection (~2 weeks). Moreover, biofunctionalization and dynamic 
stimuli significantly enhanced vascular remodeling of both smooth 
muscle and endothelium (~6 weeks). Desirable biocompatibility in 
vivo assured the safety of implantation, and investigations of 
vasculature tissue development in immunodeficient mice confirmed 
the design's effectiveness.  The advanced successes in creating 
biomimetic, functional vasculature showed significant potential for 
producing a complex vascularized tissue/organ concerning clinical 
transplantation [329].
Concluding remarks and future perspective
The 3D-bioprinting technology is accelerating innovation in a variety 
of disciplines and is making inroads into the fields of medicine and 
biology, particularly in the design and fabrication of 3D cell culture 
structures. It enables the rapid construction of scaffolds while 
sustaining a high deal of control over the matrix architecture. Among 
various 3D-bioprinting approaches, EBB is the most convenient, 
affordable, and common one, which has been considered a 
revolutionary technique in tissue biofabrication. The rapidly 
expanding research area in this filed is hydrogel-based EBB that 
stands out for its unique advantages, so that has been extensively 
explored the generation of different tissue constructs.
Looking at the literature, the principal challenges of developing 
hydrogel-based EBB can be categorized in four main categories: (1) 
bioink selection and process parameter optimization in the printing 
of various tissues, (2) enhancement in mechanical strength and bio-
functionality of the printed constructs, (3) vascularization of the 
target tissue, and (4) commercialization and mass-market 
challenges. To address the first two issues, there is a wealth of 
current literature presenting the laboratory studies to create 
functional 3D constructs. Accordingly, EBB capabilities to achieve 
personalizing of target tissues through precise control over bioinks, 
printing processes, and architectural accuracy have been extensively 
reported. Although there is still an important requirement for the 
development of printable biomaterials and 3D printing mechanisms 
to replicate the functions of the tissues, it seems that focusing on the 
advantages and disadvantages of the reported fabrication 
methodology could open new avenues for future research. Thus, the 
present review manifests the recent progress in emerging 
technologies developed for the improvement of TE with a particular 
focus on most of the published 3D-printed tissues (i.e., skin, bone, 
cartilage, vascular, neural, and muscular including skeletal, cardiac, 
and smooth) exploring TE perspective and fabrication methodology. 
The potential of hydrogel-based EBB has been extended by 
researchers through developing coaxial nozzles and multi-dispenser 
apparatuses. Coaxial nozzles have been extensively implemented in 
engineering microchannels and vascular networks. Multi-dispenser 
printing systems frequently facilitate the fabrication of tissues with 
high architectural and functional complexities (e.g., cartilages, bone, 
and muscle tissues). Furthermore, hybrid bioprinting approaches are 
advantageous for incorporating multiple biomaterials and fabricating 
complicated constructs with structural and functional heterogeneity. 
Through these improvements and novel techniques, artificial 
transplantable tissues are possible to be printed in a short time with 
a fine micro/ and macrostructure as well as practical functionalities.
The most emerging methods reviewed in the article are as follows:
- hybrid 3D bioprinting i.e., combination of the EBB with:
o Electrospinning: electrospinning and EBB have been 
known as prominent potentials in the fabrication of 
complicated constructs such as bone and cartilage 
tissues. Combining these two techniques has 
successfully succeeded some of the inherent limitations 
of each method (e.g., the tight intertwining of 
electrospun fibers that limit cell migration, and the 
insufficient resolution of EEB). 
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o Microfluidic: the microfluidic technologies and organ-
on-chip platforms offer the capability of mimicking the 
physiological, mechanical, and chemical attributes of 
native tissues. Although the convergence of microfluidic 
with EBB has led to a significant leap in the 
vascularization of engineered tissues, several issues 
have been reported to be solved. For instance, EBB 
achieves prevalence due to its low cost and mild printing 
conditions; however, it is not quite applicable for a 
microfluidic platform owing to limited resolution and 
surface roughness. Although the microfluidic bioprinting 
approach is emerging to fabricate complex tissue 
constructs, further developments in the bioprinting 
processes and bioinks are required for its wide 
application in the generation of functional tissues.
- In situ bioprinting: the recent in situ bioprinting studies have 
pleasantly grasped the very conceptual idea of tissue 
biofabrication directly on the living body. Regarding its intrinsic 
advantages, increased efforts are being done to improve it 
through the development of more advanced bioinks, higher 
resolution of bioprinting methods, and automation of bioprinting 
processes. Besides, other capacities such as real-time monitoring, 
sensors for investigating critical parameters, miniaturization of the 
device, higher freedom, and printing on a dynamic surface, can be 
integrated with in situ bioprinting. Thus far, attempts have been 
made to fabricate tissues on the outer organs (i.e., skin, cartilage, 
and bone), which can be safely arrested and immobilized while 
printing.
Besides above mentioned methods which have been extensively 
explored in vitro and in vivo, some innovative approaches have been 
reported recently, to overcome reviewed challenges and accomplish 
more accurate and complicated architectures. For instance, the 
capability of printing multiple materials through a single nozzle 
strives to overcome some restrictions of multi-nozzle 3D bioprinters 
(e. g., enhancement of the printing time while changing between 
materials, requiring specific calibration for all the printheads before 
every print) [51]. Accordingly, different techniques have been used 
for manufacturing continuous single-nozzle multi-material (SNMM) 
micro-extrusion bioprinters [330]. Moreover, a novel multimaterial 
multinozzle 3D printing method (MM3D) has been introduced for 
generating voxelated soft materials, in which through a uniform 
printing process, complex architectures with controlled composition, 
function, and structure in a voxel-by-voxel manner could be 
fabricated. MM3D is capable of presenting an efficient approach to 
fabricate a broad range of high-performance structural, functional, 
and biological materials, which could exclude periodicity restrictions 
of existing printhead design, progress feature resolution and 
minimise printing time [331].
Regarding EBB is hampered by the insufficiency of printing low-
viscosity materials, the dual-step crosslinking method implemented 
for cytocompatible bioprinting of a wide range of Gel-AGE bioink 
formulations, providing the fabrication of soft and permissive 
constructs, e.g. vascular and neural tissue. This approach could open 
a promising gateway to produce complex constructs while 
maintaining a cell-permissive environment [332]. Continuous chaotic 
printing is another approach that allows careful control of the spatial 
microstructures (i.e. the number of layers and the average spacing 
between them) within a single 3D printed fiber. The principal part of 
this technological platform is the use of an on-line static mixer in the 
printhead for presenting a partial mixing of various materials as they 
are coextruded through the nozzle [333].  
As the bioprinting matured, substantive roadblocks to obtaining the 
architecture and resolution of native tissues became obvious. 
Several groups have now demonstrated that innovations in the 
materials used for printing can promote transformative advances in 
both tissue architecture and resolution. Recently, the freeform 
reversible embedding of suspended hydrogels (FRESH) bioprinting 
technique [224] was improved, and individual filaments of collagen 
as thin as 20 mm in diameter were printed [334]. Although it is a 
notable improvement towards volumetric patterning of natural 
biomaterials at cellular resolution, and such astonishing 
improvement in resolution would lead the EBB field to a new era, the 
field still requires to address how to best seamlessly combine cells 
into FRESH-printed constructs [335]. It should be considered that the 
FRESH method is the only technique to obtain volumetric patterning 
using EBB. The principal contrast between FRESH method and other 
EBB approaches is that FRESH is achieved within a dissolvable 
support bath [335]. Recent progress in the application of the 
jamming transition of granular hydrogels for supporting baths and 
bioinks expresses a potential paradigm shift in the EBB. They have 
appeared as a powerful platform for the 3D bioprinting because of 
the dynamic structures, unique shear-thinning, and self-healing 
characteristics [336,337]. 
In addition to discussed current progress associating to EBB, the 4D 
bioprinting, in which the concept of time is integrated with 3D 
bioprinting, has currently emerged as the next-generation solution 
of tissue engineering as it presents the possibility of constructing 
complex and functional structures [338]. Integration of the fourth 
dimension “time”  in 4D bioprinting, allows for the continued control 
over the evolution of 3D printed biomaterials and bioinks, provide 
programming and regulating the formation of biomimetic tissues 
from the printed constructs to achieve more native-like results [339]. 
The 4D bioprinting can be used to fabricate dynamic 3D-patterned 
biological architectures that will change their shapes under various 
stimuli by employing stimuli-responsive materials. The functional 
transformation and maturation of printed cell-laden structures over 
time present an unprecedented potential for TE. The shape memory 
characteristics of printed constructs could address the need for 
personalized tissue defect repairs [340]. Applying this technique, 
researchers have fabricated bioconstructs capable of transforming 
into very complex structures which are difficult to directly achieve by 
3D bioprinting or other systems. Despite the concise history of 4D 
bioprinting, recent fast progress with a focus on developing novel 4D 
printable materials, exploring novel methods to precisely control the 
process, and seeking biomedical applications is testified in this field 
[341]. In sum, 4D bioprinting has opened new windows for 
biofabrication, and it has shown the magnificent potential to 
revolutionize tissue engineering, drug delivery, and other fields 
[338]. However, it is in its infancy, and there is still a long way to 
achieve clinical applications. With the progress of material science, 
printing technology, software, and numerical modelling, 4D 
bioprinting would make a huge step forward in achieving the real 
applications [341,342].
Finally, it should be highlighted that despite extensive efforts that 
have been made in recent years to develop hydrogel-based EBB and 
Page 15 of 40 Biomateri ls Science
B
io
m
at
er
ia
ls
S
ci
en
ce
A
cc
ep
te
d
M
an
us
cr
ip
t
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
9 
O
ct
ob
er
 2
02
0.
 D
ow
nl
oa
de
d 
on
 1
0/
11
/2
02
0 
9:
30
:2
2 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/D0BM00973C
Review       Biomaterials Science
16 | Biomater. Sci. This journal is © The Royal Society of Chemistry 
Please do not adjust margins
Please do not adjust margins
proposed notions by interdisciplinary researchers to overcome the 
challenges, it is still in the infancy stage. Besides, there is no clear 
picture of which method is best to overwhelm hurdles and 
accomplish more accurate and complicated architectures 
considering that all these methods as the field are still at early stages 
and much more studies should be performed in this area towards 
engineering functional human tissues and organs.
The present review outlines that fast-developing fabrication 
technologies in the area of EBB could open up new avenues toward 
more innovative treatments in the future. Furthermore, challenges 
such as the economics of scale, the cost-effectiveness of the final 
product, regulatory standards, and ethical considerations, are still 
the foremost issues for commercialization of bioprinted tissues for 
personalized medicine. It is expected that multidisciplinary 
approaches provide further convenient ways to overcome the 
mentioned hurdles.
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Table 1. Overview of the advanced fabrication strategies of extrusion-based bioprinting for tissue engineering
Strategies Tissue Biomaterials* Cells** Reference
Collagen type I (rat tail) hFBs, hKCs [104] 
Skin
Collagen type I (rat tail) hFBs, hKCs [105]
GelMA, PVA SaOS-2 [157] 
GelMA, silicate nanoplatelets HUVEC, hMSCs [159]
Fibrinogen, gelatin, pluronic F127,
silicon perfusion chips HUVEC, hNDFs, hBMSCs [158]
GELMA, pluronic F127 Rat BMSCs [343] 
Alginate, PVA Rat BMSCs [344]
Alginate, PVA, HA MC3T3-E1 [143]
Gelatin, PVA MG63 [345]
Alginate, pluronic F127 hBMSCs [346]
RGD-Ɣ alginate, PCL Pig BMSCs [134]
Alginate, gelatin, PCL, polydopamine modified 
calcium silicate
HUVEC
Wharton's jelly MSCs [135]
HA, gelatin, atelocollagen, PCL, PLGA MC3T3-E1 [138]
Bone
PCL, alginate MC3T3-E1 [137]
PCL, alginate chondrocytes [194]
Gellan, alginate, BioCartilage (cartilage 
extracellular matrix particles) chondrocytes [211]
PCL, PLGA, TGF 3, CTGF MSCs [347]
GelMA, pluronic F-127 BMSCs, chondrocytes, ACPC [207]
Cartilage
PCL, alginate, PEG hASCs [348]
Gelatin, alginate, fibrinogen ADSC, hepatocyte [225]
Alginate, xanthan gum - [226]Vascular
Alginate Human glioma U87-MG [227]
Neural Matrigel, gelatin, fibrin, GelMa, PEGDA, alginate, methylcellulose NPCs, OPCs [255]
Multi-dispenser bioprinting
Skeletal 
Muscle
HA, gelatin, fibrinogen
C2C12, NIH/3T3 [275]
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Heart dECM hCPCs, hTMSCs [315]
Fibrinogen, gelatin, aprotinin, glycerol, 
HA NRVCMs [308]
Cardiac 
muscle
Alginate, calcium carbonate iPSCs-dCMs,ECs, RNCMs , HUVECs, lumen-supporting fibroblasts [319]
Skin Alginate, collagen hFBs, hKCs [107]
Alginate, collagen MG63, hASCs [160]
Alginate, collagen, fibronectin Rat BMSCs [161]
HPMC, alginate MC3T3-E1 [162]Bone
Collagen, GELMA, alginate MC3T3-E1 [163]
GelMa, HAMa
ADSCs
[216]Cartilage
GelMa, HAMa MSCs [217]
Alginate, CNTs HCASMCs [220]
Alginate L929 [230]
GPT HUVECs, HDFs [56]
Vascular
GelMA, SA, PEGTA HUVECs, hMSCs [232]
Alginate, Matrigel hNSC [252]
Neural Alginate MNPCs [253]
Skeletal 
Muscle mdECM, vdECM hSKMs, HUVECs [290]
Alginate HUVSMCs [326]
Coaxial bioprinting
Smooth 
Muscle GelMA/C HCASMCs, hBMSCs, HUVECs [329]
Skin nanofibers: PCL, silk sericinstruts: chitosan, alginate hFBs [119]
nanofibers: PCL, gelatin
struts: PCL MC3T3-E1 [166]
Bone
nanofibers: PCL
struts: alginate MG63 [167]
nanofibers: PCL, collagen I,
struts: collagen I, PEO C2C12 [297]
nanofibers: PVA
struts: PCL, collagen I C2C12 [298]
Hybrid 
bioprinting Electrospinning + EBB
Skeletal 
Muscle
nanofibers: alginate, PEO, lecithin struts: 
alginate, PCL
MG63 [299]
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nanofiber: alginate
struts: PCL, collagen C2C12, HUVECs [300]
Cartilage Gelatin, PLGA chondrocytes [212]
Alginate hFBs [117]
Microfluidic + EBB Skin Alginate, fibrin, collagen I, HA hFBs, hKCs [118]
Bone
Collagen type I, GelMA, Alginate
MC3T3E1, ATCC [163]
Alginate, chitosan CPCs [228]
Alginate HUVEC [231]
PEGOA, GelMA, alginate C2C12, skeletal myocytes,NIH/3T3, fibroblasts [233]
Vascular
Alginate Fibroblasts, smooth muscle cells,ECs [237]
PEG, fibrinogen C2C12 and BALB/3T3   [294]Skeletal 
Muscle Alginate, PF C2C12 [295]
GelMA, alginate HUVECs, RNCMs, hiPSC-CMs [316]Cardiac 
muscle Alginate, PF iPSCs-dCMs, HUVEC [317]
Smooth 
muscle Small intestine dECM HASMCs, HISMCs [325]
GelMA/alginate HUVECs, MCF7 breast cancer cells, NIH/3T3 mouse fibroblasts [72]
Microfluidic + coaxial 
bioprinting
General 
cell culture GelMA, alginate HUVECs [73] 
Bone PCL, pluronic F-127, gelatin, fibrinogen, HA, glycerol
hAFSCs
[136] 
Cartilage PCL, pluronic F-127, gelatin, fibrinogen, HA, glycerol
Rabbit ear chondrocytes
[136]
PCL, pluronic F-127, gelatin, fibrinogen, 
HA, glycerol
Mouse C2C12 myoblasts
[136]
Microfluidic + multi-
dispenser bioprinting
Skeletal 
muscle Gelatin, PCL hMPCs
[293]
cartilage GelMa, HAMa IPFP- ASCs [215]
UV-light beam Cardiac 
muscle
Alginate, Methacrylated collagen I,
MeCol, CNTs HCAECs [318]
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*: GelMA: gelatin-methacryloyl; PVA: polyvinyl alcohol; PCL: poly(ε-caprolactone); PEG: polyethylene glycol; PEGDA: poly (ethylene glycol) diacrylate; HA: hyaluronic acid; dECM: decellularized extracellular 
matrix; HPMC: hydroxypropyl methyl cellulose; CNTs: carbon nanotubes; PEGTA: 4-arm poly(ethylene glycol)-tetra-acrylate; GPT: gelatin–PEG–tyramine; mdECM: skeletal muscle dECM; vdECM: vascular 
dECM; GelMA/C: blend of GelMA and nanofibrillar cellulose; PEO: poly(ethylene oxide); Collagen type I: collagen I ; PLGA: poly lactic-co-glycolic acid; PEGOA: PEG acrylate with tripentaerythritol core; PF: 
polyethylene glycol monoacrylate-Fibrinogen; HAMa: hyaluronic acid–methacrylate;
**: hFBs: human skin fibroblasts; hKCs: human keratinocytes; SaOS-2: sarcoma osteogenic; HUVECs: human umbilical vein  endothelial cells; hMSCs: human mesenchymal stem cells; hNDFs: Human 
neonatal dermal fibroblasts; hBMSCs: human bone marrow mesenchymal stem cells; BMSCs: bone marrow mesenchymal stromal cells; ACPC: articular cartilage-resident chondroprogenitor cell; ADSCs: 
adipose-derived mesenchymal stem/stromal cells; hASCs: human adipose derived stem cells; NPCs: neuronal progenitor cells; OPCs: oligodendrocyte progenitor cells; hCPCs: human cardiac progenitor 
cells; hTMSCs: human turbinate tissue-derived MSCs; NRVCMs: neonatal rat ventricular cardiomyocytes; iPSCs-dCMs: induced pluripotent stem cells-derived cardoimyocytes; ECs: endothelial cells; RNCMs: 
rat neonatal cardoimyocytes, HUVECs: human umbilical vein endothelial cells; HDFs:  human dermal fibroblasts; hNSC: human neuronal stem cells; MNPCs: mouse neural progenitor cells; MSCs: 
mesenchymal stem cells; HCASMCs: human coronary artery smooth muscle cells; hSKMs: human skeletal muscle cells; HUVSMCs: human umbilical vein smooth muscle cells; CPCs: cartilage progenitor 
cells; hiPSC-CMs: human induced pluripotent stem cells stem cardiomyocytes; HASMCs: primary human airway smooth muscle cells; HISMCs: primary human intestinal smooth muscle cells; hAFSCs: human 
amniotic fluid-derived stem cells; hMPCs: human muscle progenitor cells; IPFP- ASCs: Human infrapatellar fat pad derived adipose stem cells; HCAECs: human coronary artery endothelial cells
Page 34 of 40Biomaterials Science
B
io
m
at
er
ia
ls
S
ci
en
ce
A
cc
ep
te
d
M
an
us
cr
ip
t
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
9 
O
ct
ob
er
 2
02
0.
 D
ow
nl
oa
de
d 
on
 1
0/
11
/2
02
0 
9:
30
:2
2 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/D0BM00973C
Biomaterials Science  Review
This journal is © The Royal Society of Chemistry   Biomater. Sci. | 35
Please do not adjust margins
Please do not adjust margins
Figure 1. Schematic illustration of tissue engineering process using extrusion-based bioprinting.
Figure 2. 3D bioprinting of skin tissue (a) Cryogenic free-form extrusion bioprinting of decellularized small intestinal submucosa (dSIS) scaffolds with distinctive 
physicochemical characteristics and enhanced biocompatibility. Reproduced from Ref. [102] with permission of IOP Publishing, © 2018; (b) Employing a 
handheld bioprinter to generate skin cell-laden sheets with controllable thickness, width, and composition via incorporating dermal and epidermal cells into 
various cross-linkable hydrogels. Reproduced from Ref. [118] with permission of Royal Society of Chemistry, © 2018.
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Figure 3. 3D bioprinting of bone tissue (a) Using sacrificial ink to create a 3D cell-laden vascularized tissues integrated parenchyma, stroma, and endothelium 
into a single thick tissue bioprinted in a perfusion chip. Reproduced from Ref. [158] with permission of National Academy of Sciences, © 2016; (b) A cell printing 
process with a core (α-TCP) / shell (alginate + cell) geometry with post-fabrication process, involving the crosslinking of hydrogel shell and cementation of the 
ceramic core. Reproduced from Ref. [162] with permission of Royal Society of Chemistry, © 2016; (c) Hierarchical scaffolds consisting of micro-sized struts 
with the appropriate inter-layered nanofibers between the struts supplemented with osteoblast-like cell-laden alginate struts. Reproduced from Ref. [167] 
with permission of Royal Society of Chemistry, © 2014.
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Figure 4. 3D bioprinting of cartilage tissue (a) Fabrication of cartilaginous tissue using PCL and chondrocyte cell-laden alginate via multi-dispenser bioprinting. 
Enhanced cartilage tissue and collagen (type II) fibril formation were revealed via histochemical and immunohistochemical analyses of the retrieved implants 
after 4 weeks. Reproduced from Ref. [194] with permission of John Wiley & Sons, Ltd., © 2013; (b) Fabrication of cartilage tissues utilizing an integrated tissue–
organ printer (ITOP). The results manifested the generation of ear-shaped cartilage with resilience characteristics similar to those of native cartilage (rabbit 
ear). Reproduced from Ref. [136] with permission of Nature America, Inc., © 2016. (c) Fabrication of electrospun fiber-based 3D scaffolds with controlled 3D 
shapes and large pores as well as ECM biomimetic surface structure. The chondrocytes-laden scaffolds received satisfying cartilage regeneration and form 
preservation in vivo. Reproduced from Ref. [212] with permission of Elsevier Ltd., © 2019.
Page 37 of 40 Biomateri ls Science
B
io
m
at
er
ia
ls
S
ci
en
ce
A
cc
ep
te
d
M
an
us
cr
ip
t
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
9 
O
ct
ob
er
 2
02
0.
 D
ow
nl
oa
de
d 
on
 1
0/
11
/2
02
0 
9:
30
:2
2 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/D0BM00973C
Review       Biomaterials Science
38 | Biomater. Sci. This journal is © The Royal Society of Chemistry 
Please do not adjust margins
Please do not adjust margins
Figure 5. 3D bioprinting of vascular tissue(a) schematic showing the components of the multichannel coaxial extrusion system and cross-sectional views of the 
hollow structures of GelMa-based bioinks, showing walls of a single layered tube and a double-layered tube. Reproduced from Ref. [233] with permission of 
WILEY-VCH Verlag GmbH & Co., © 2018; (b) An overview of multi-level fluidic channels composed of macrochannels and microchannels, longitudinal section 
of the single layer structure, and the printed vessel-like structure containing three kinds of vascular cells with three colors: red-L929, green-MOVAS, and 
orange-HUVEC. Reproduced from Ref. [237] with permission of American Chemical Society, © 2017; (c) Schematic illustration of the inflammation-mediated 
process for vascular remodeling, Optical images of the implanted grafts in vivo view (left) and in vitro view (right) after 1 month, and blood flow (39.4 cm/s) 
assessed with ultrasonography 1 day after implantation. Reproduced from Ref. [236] with permission of American Chemical Society, © 2019;
Figure 6. 3D bioprinting of nerve tissue (a) Schematic representations of brain layer structures and cortical neurons encapsulated in RGD-gellan gum after 5 
days of culture and confocal microscope images of neuronal 3D culture models after 5 days of culture. Reproduced from Ref. [251] with permission of 
Elsevier Ltd., © 2015; (b) Diagram of the co-extrusion set-up, schematic illustration of a neuronal capsule, and micrographs of a fixed neuronal capsule by 
bright field microscopy and fluorescence confocal microscopy. Reproduced from Ref. [252] with permission of Royal Society of Chemistry, © 2016; (c) 
Schematic of the spinal cord designed for a 3D-bioprinted multichannel scaffold modeling, schematic overview of the 3D bioprinting process, and image of 
3D-printed different cell encapsulated channel showing the mature neuronal marker expression. Reproduced from Ref. [255] with permission of WILEY-VCH 
Verlag GmbH & Co., © 2018;
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Figure 7. 3D bioprinting of muscular tissue (a) Fabrication of heterogeneous, multi-cellular cardiac tissue composed of Human Umbilical Vein Endothelial Cells 
(HUVECs), and induced pluripotent cell-derived cardiomyocytes (iPSC-CMs) cells via hybrid bioprinting (a microfluidic printing head (MPH) coupled to a co-
axial nozzle extruder). Reproduced from Ref. [317] with permission of Springer Nature, © 2018; (b) Development and application of thoroughly personalized 
contracting cardiac patches employing patient’s cells. The structure and function of the patches were investigated in vitro, and the evaluation of cardiac cell 
morphology after transplantation exhibited elongated cardiomyocytes with massive actinin striation. Reproduced from Ref. [319] with permission of WILEY-
VCH Verlag GmbH & Co., © 2019; (c) Development of scaffolds for co-culturing myoblasts and HUVECs via employing cell electrospinning and 3D printing. 
Striated patterns and enhanced myogenic gene markers showed a mature stage of myogenic differentiation with vascularization. Reproduced from Ref. [300] 
with permission of  Elsevier Ltd., © 2020 .
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